{"parse":{"title":"Artificial cell","pageid":4630125,"revid":860494655,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:352px;\"><a href=\"/wiki/File:Standard_and_drug_delivery_artificial_cells_.png\" class=\"image\"><img alt=\"Two types of artificial cells, one with contents meant to stay inside, the other for drug delivery and diffusing contents.\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/5/54/Standard_and_drug_delivery_artificial_cells_.png/350px-Standard_and_drug_delivery_artificial_cells_.png\" width=\"350\" height=\"382\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/en/5/54/Standard_and_drug_delivery_artificial_cells_.png 1.5x\" data-file-width=\"366\" data-file-height=\"399\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Standard_and_drug_delivery_artificial_cells_.png\" class=\"internal\" title=\"Enlarge\"></a></div>Standard artificial cell (top) and drug delivery artificial cell (bottom).</div></div></div>\n<p>An <b>artificial cell</b> or <b>minimal cell</b> is an engineered particle that mimics one or many functions of a <a href=\"/wiki/Cell_(biology)\" title=\"Cell (biology)\">biological cell</a>. The term does not refer to a specific physical entity, but rather to the idea that certain functions or structures of biological cells can be replaced or supplemented with a synthetic entity. Often, artificial cells are biological or polymeric membranes which enclose biologically active materials. As such, <a href=\"/wiki/Nanoparticle\" title=\"Nanoparticle\">nanoparticles</a>, <a href=\"/wiki/Liposome\" title=\"Liposome\">liposomes</a>, <a href=\"/wiki/Polymersome\" title=\"Polymersome\">polymersomes</a>, microcapsules and a number of other particles have qualified as artificial cells. <a href=\"/wiki/Micro-encapsulation\" title=\"Micro-encapsulation\">Micro-encapsulation</a> allows for <a href=\"/wiki/Metabolism\" title=\"Metabolism\">metabolism</a> within the membrane, exchange of small molecules and prevention of passage of large substances across it.<sup id=\"cite_ref-Chang_2007_1-0\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prakash_2-0\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> The main advantages of encapsulation include improved mimicry in the body, increased <a href=\"/wiki/Solubility\" title=\"Solubility\">solubility</a> of the cargo and decreased <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune responses</a>. Notably, artificial cells have been clinically successful in <a href=\"/wiki/Hemoperfusion\" title=\"Hemoperfusion\">hemoperfusion</a>.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>In the area of <a href=\"/wiki/Synthetic_biology\" title=\"Synthetic biology\">synthetic biology</a>, a \"living\" artificial cell has been defined as a completely synthetically made cell that can capture <a href=\"/wiki/Energy\" title=\"Energy\">energy</a>, maintain <a href=\"/wiki/Electrochemical_gradient\" title=\"Electrochemical gradient\">ion gradients</a>, contain <a href=\"/wiki/Macromolecule\" title=\"Macromolecule\">macromolecules</a> as well as store information and have the ability to <a href=\"/wiki/Mutate\" class=\"mw-redirect\" title=\"Mutate\">mutate</a>.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> Such a cell is not technically feasible yet, but a variation of an artificial cell has been created in which a completely synthetic <a href=\"/wiki/Genome\" title=\"Genome\">genome</a> was introduced to genomically emptied host cells.<sup id=\"cite_ref-gibson52_5-0\" class=\"reference\"><a href=\"#cite_note-gibson52-5\">&#91;5&#93;</a></sup> Although not completely artificial because the <a href=\"/wiki/Cytoplasm\" title=\"Cytoplasm\"> cytoplasmic components</a> as well as the <a href=\"/wiki/Cell_membrane\" title=\"Cell membrane\">membrane</a> from the host cell are kept, the engineered cell is under control of a synthetic genome and is able to <a href=\"/wiki/Self-replication\" title=\"Self-replication\">replicate</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Materials\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Materials</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Preparation\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Preparation</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#High-pressure_homogenization\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">High-pressure homogenization</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Microfluidization\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Microfluidization</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Drop_method\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Drop method</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Emulsion_method\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Emulsion method</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Clinical_relevance\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Clinical relevance</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Drug_release_and_delivery\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Drug release and delivery</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Enzyme_therapy\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Enzyme therapy</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Gene_therapy\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Gene therapy</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Hemoperfusion\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">Hemoperfusion</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Encapsulated_cells\"><span class=\"tocnumber\">4.5</span> <span class=\"toctext\">Encapsulated cells</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-14\"><a href=\"#Encapsulated_hepatocytes\"><span class=\"tocnumber\">4.5.1</span> <span class=\"toctext\">Encapsulated hepatocytes</span></a></li>\n<li class=\"toclevel-3 tocsection-15\"><a href=\"#Encapsulated_bacterial_cells\"><span class=\"tocnumber\">4.5.2</span> <span class=\"toctext\">Encapsulated bacterial cells</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-16\"><a href=\"#Artificial_blood_cell\"><span class=\"tocnumber\">4.6</span> <span class=\"toctext\">Artificial blood cell</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-17\"><a href=\"#Oxygen_carriers\"><span class=\"tocnumber\">4.6.1</span> <span class=\"toctext\">Oxygen carriers</span></a></li>\n<li class=\"toclevel-3 tocsection-18\"><a href=\"#Red_blood_cells\"><span class=\"tocnumber\">4.6.2</span> <span class=\"toctext\">Red blood cells</span></a></li>\n<li class=\"toclevel-3 tocsection-19\"><a href=\"#Leuko-polymersome\"><span class=\"tocnumber\">4.6.3</span> <span class=\"toctext\">Leuko-polymersome</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#Synthetic_cells\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Synthetic cells</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#The_minimal_cell\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">The minimal cell</span></a></li>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Electronic_artificial_cell\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Electronic artificial cell</span></a></li>\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Ethics_and_controversy\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Ethics and controversy</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-24\"><a href=\"#See_also\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-25\"><a href=\"#References\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-26\"><a href=\"#External_links\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The first artificial cells were developed by <a href=\"/wiki/Thomas_Chang\" title=\"Thomas Chang\">Thomas Chang</a> at <a href=\"/wiki/McGill_University\" title=\"McGill University\">McGill University</a> in the 1960s.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> These cells consisted of ultrathin membranes of nylon, collodion or crosslinked protein whose <a href=\"/wiki/Semipermeable\" class=\"mw-redirect\" title=\"Semipermeable\">semipermeable</a> properties allowed <a href=\"/wiki/Diffusion\" title=\"Diffusion\">diffusion</a> of small molecules in and out of the cell. These cells were micron-sized and contained  <a href=\"/wiki/Cell_(biology)\" title=\"Cell (biology)\">cell</a>, <a href=\"/wiki/Enzymes\" class=\"mw-redirect\" title=\"Enzymes\">enzymes</a>, <a href=\"/wiki/Hemoglobin\" title=\"Hemoglobin\">hemoglobin</a>, magnetic materials, <a href=\"/wiki/Adsorption\" title=\"Adsorption\">adsorbents</a> and <a href=\"/wiki/Proteins\" class=\"mw-redirect\" title=\"Proteins\">proteins</a>.<sup id=\"cite_ref-Chang_2007_1-1\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup>\n</p><p>Later artificial cells have ranged from hundred-micrometer to nanometer dimensions and can carry microorganisms, <a href=\"/wiki/Vaccines\" class=\"mw-redirect\" title=\"Vaccines\">vaccines</a>, <a href=\"/wiki/Genes\" class=\"mw-redirect\" title=\"Genes\">genes</a>, drugs, <a href=\"/wiki/Hormones\" class=\"mw-redirect\" title=\"Hormones\">hormones</a> and <a href=\"/wiki/Peptides\" class=\"mw-redirect\" title=\"Peptides\">peptides</a>.<sup id=\"cite_ref-Chang_2007_1-2\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup> The first clinical use of artificial cells was in <a href=\"/wiki/Hemoperfusion\" title=\"Hemoperfusion\">hemoperfusion</a> by the encapsulation of <a href=\"/wiki/Activated_charcoal\" class=\"mw-redirect\" title=\"Activated charcoal\">activated charcoal</a>.<sup id=\"cite_ref-Chang_1996_7-0\" class=\"reference\"><a href=\"#cite_note-Chang_1996-7\">&#91;7&#93;</a></sup>\n</p><p>In the 1970s, researchers were able to introduce enzymes, proteins and hormones to biodegradable microcapsules, later leading to clinical use in diseases such as <a href=\"/wiki/Lesch-Nyhan_syndrome\" class=\"mw-redirect\" title=\"Lesch-Nyhan syndrome\">Lesch-Nyhan syndrome</a>.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> Although Chang's initial research focused on artificial <a href=\"/wiki/Red_blood_cells\" class=\"mw-redirect\" title=\"Red blood cells\">red blood cells</a>, only in the mid-1990s were biodegradable artificial red blood cells developed.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> Artificial cells in biological cell encapsulation were first used in the clinic in 1994 for treatment in a diabetic patient<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> and since then other types of cells such as <a href=\"/wiki/Hepatocytes\" class=\"mw-redirect\" title=\"Hepatocytes\">hepatocytes</a>, adult <a href=\"/wiki/Stem_cells\" class=\"mw-redirect\" title=\"Stem cells\">stem cells</a> and genetically engineered cells have been encapsulated and are under study for use in tissue regeneration.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>On December 29, 2011, chemists at <a href=\"/wiki/Harvard_University\" title=\"Harvard University\">Harvard University</a> reported the creation of an artificial <a href=\"/wiki/Cell_membrane\" title=\"Cell membrane\">cell membrane</a>.<sup id=\"cite_ref-JACS-20111229_13-0\" class=\"reference\"><a href=\"#cite_note-JACS-20111229-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-SD-20120125_14-0\" class=\"reference\"><a href=\"#cite_note-SD-20120125-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-KZ-20120126_15-0\" class=\"reference\"><a href=\"#cite_note-KZ-20120126-15\">&#91;15&#93;</a></sup>\n</p><p>By 2014, self-replicating, synthetic bacterial cells with cell walls and synthetic DNA had been produced. In January of that year researchers produced an artificial <a href=\"/wiki/Eukaryotic_cell\" class=\"mw-redirect\" title=\"Eukaryotic cell\">eukaryotic cell</a> capable of undertaking multiple chemical reactions through working <a href=\"/wiki/Organelle\" title=\"Organelle\">organelles</a>.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p><p>In September 2018, researchers at the <a href=\"/wiki/University_of_California\" title=\"University of California\">University of California</a> developed artificial cells that can kill bacteria.&#160;The cells were engineered from the bottom-up \u2014 like Lego blocks \u2014 to destroy bacteria.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Materials\">Materials</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=2\" title=\"Edit section: Materials\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:452px;\"><a href=\"/wiki/File:Artificial_cell_membranes.png\" class=\"image\"><img alt=\"Different types of artificial cell membranes.\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1e/Artificial_cell_membranes.png/450px-Artificial_cell_membranes.png\" width=\"450\" height=\"198\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/en/1/1e/Artificial_cell_membranes.png 1.5x\" data-file-width=\"644\" data-file-height=\"284\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Artificial_cell_membranes.png\" class=\"internal\" title=\"Enlarge\"></a></div>Representative types of artificial cell membranes.</div></div></div>\n<p>Membranes for artificial cells be made of simple <a href=\"/wiki/Polymers\" class=\"mw-redirect\" title=\"Polymers\">polymers</a>, crosslinked proteins, <a href=\"/wiki/Lipid_membranes\" class=\"mw-redirect\" title=\"Lipid membranes\">lipid membranes</a> or polymer-lipid complexes. Further, membranes can be engineered to present surface <a href=\"/wiki/Proteins\" class=\"mw-redirect\" title=\"Proteins\">proteins</a> such as <a href=\"/wiki/Albumin\" title=\"Albumin\">albumin</a>, <a href=\"/wiki/Antigens\" class=\"mw-redirect\" title=\"Antigens\">antigens</a>, <a href=\"/wiki/Na%2B/K%2B-ATPase\" title=\"Na+/K+-ATPase\">Na/K-ATPase</a> carriers, or pores such as <a href=\"/wiki/Ion_channels\" class=\"mw-redirect\" title=\"Ion channels\">ion channels</a>.\nCommonly used materials for the production of membranes include hydrogel polymers such as <a href=\"/wiki/Alginic_acid\" title=\"Alginic acid\">alginate</a>, <a href=\"/wiki/Cellulose\" title=\"Cellulose\">cellulose</a> and <a href=\"/wiki/Thermoplastic\" title=\"Thermoplastic\">thermoplastic</a> polymers such as hydroxyethyl methacrylate-methyl methacrylate (HEMA- MMA), polyacrylonitrile-polyvinyl chloride (PAN-PVC), as well as variations of the above-mentioned.<sup id=\"cite_ref-Prakash_2-1\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> The material used determines the permeability of the cell membrane, which for polymer depends on the <a href=\"/wiki/Molecular_Weight_Cut_Off\" class=\"mw-redirect\" title=\"Molecular Weight Cut Off\">molecular weight cut off</a> (MWCO).<sup id=\"cite_ref-Prakash_2-2\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> The MWCO is the maximum molecular weight of a molecule that may freely pass through the pores and is important in determining adequate <a href=\"/wiki/Diffusion\" title=\"Diffusion\">diffusion</a> of nutrients, waste and other critical molecules.\nHydrophilic polymers have the potential to be <a href=\"/wiki/Biocompatibility\" title=\"Biocompatibility\">biocompatible</a> and can be fabricated into a variety of forms which include polymer <a href=\"/wiki/Micelles\" class=\"mw-redirect\" title=\"Micelles\">micelles</a>, <a href=\"/wiki/Sol-gel\" class=\"mw-redirect\" title=\"Sol-gel\">sol-gel</a> mixtures, physical blends and crosslinked particles and nanoparticles.<sup id=\"cite_ref-Prakash_2-3\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> Of special interest are stimuli-responsive polymers that respond to <a href=\"/wiki/PH\" title=\"PH\">pH</a> or temperature changes for the use in targeted delivery. These polymers may be administered in the liquid form through a macroscopic injection and solidify or gel <i>in situ</i> because of the difference in pH or temperature. <a href=\"/wiki/Nanoparticle\" title=\"Nanoparticle\">Nanoparticle</a> and <a href=\"/wiki/Liposome\" title=\"Liposome\">liposome</a> preparations are also routinely used for material encapsulation and delivery.  A major advantage of liposomes is their ability to <a href=\"/wiki/Lipid_bilayer_fusion\" title=\"Lipid bilayer fusion\">fuse</a> to cell and <a href=\"/wiki/Organelle\" title=\"Organelle\">organelle</a> membranes.\n</p>\n<h2><span class=\"mw-headline\" id=\"Preparation\">Preparation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=3\" title=\"Edit section: Preparation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Many variations for artificial cell preparation and encapsulation have been developed. Typically, vesicles such as a <a href=\"/wiki/Nanoparticle#Synthesis\" title=\"Nanoparticle\">nanoparticle</a>, <a href=\"/wiki/Polymersome#Preparation\" title=\"Polymersome\">polymersome</a> or <a href=\"/wiki/Liposome#Manufacturing\" title=\"Liposome\">liposome</a> are synthesized. An emulsion is typically made through the use of high pressure equipment such as a high pressure <a href=\"/wiki/Homogenizer\" title=\"Homogenizer\">homogenizer</a> or a <a href=\"/w/index.php?title=Microfluidizer&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Microfluidizer (page does not exist)\">Microfluidizer</a>. Two <a href=\"/wiki/Micro-encapsulation\" title=\"Micro-encapsulation\">micro-encapsulation</a> methods for nitrocellulose are also described below.\n</p>\n<h3><span class=\"mw-headline\" id=\"High-pressure_homogenization\">High-pressure homogenization</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=4\" title=\"Edit section: High-pressure homogenization\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In a high-pressure homogenizer, two liquids in oil/liquid suspension are forced through a small orifice under very high pressure. This process shears the products and allows the creation of extremely fine particles, as small as 1&#160;nm.\n</p>\n<h3><span class=\"mw-headline\" id=\"Microfluidization\">Microfluidization</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=5\" title=\"Edit section: Microfluidization\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>This technique uses a patented Microfluidizer to obtain a greater amount of homogenous suspensions that can create smaller particles than homogenizers. A homogenizer is first used to create a coarse suspension which is then pumped into the microfluidizer under high pressure. The flow is then split into two streams which will react at very high velocities in an interaction chamber until desired particle size is obtained.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup> This technique allows for large scale production of phospholipid liposomes and subsequent material nanoencapsulations.\n</p>\n<h3><span class=\"mw-headline\" id=\"Drop_method\">Drop method</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=6\" title=\"Edit section: Drop method\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In this method, a cell solution is incorporated dropwise into a <a href=\"/wiki/Collodion\" title=\"Collodion\">collodion</a> solution of cellulose nitrate. As the drop travels through the collodion, it is coated with a membrane thanks to the interfacial polymerization properties of the collodion. The cell later settles into paraffin where the membrane sets and is finally suspended a saline solution. The drop method is used for the creation of large artificial cells which encapsulate biological cells, stem cells and genetically engineered stem cells.\n</p>\n<h3><span class=\"mw-headline\" id=\"Emulsion_method\">Emulsion method</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=7\" title=\"Edit section: Emulsion method\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The <a href=\"/wiki/Emulsion\" title=\"Emulsion\">emulsion</a> method differs in that the material to be encapsulated is usually smaller and is placed in the bottom of a reaction chamber where the collodion is added on top and centrifuged, or otherwise disturbed in order to create an emulsion. The encapsulated material is then dispersed and suspended in saline solution.\n</p>\n<h2><span class=\"mw-headline\" id=\"Clinical_relevance\">Clinical relevance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=8\" title=\"Edit section: Clinical relevance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Drug_release_and_delivery\">Drug release and delivery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=9\" title=\"Edit section: Drug release and delivery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Artificial cells used for <a href=\"/wiki/Drug_delivery\" title=\"Drug delivery\">drug delivery</a> differ from other artificial cells since their contents are intended to diffuse out of the membrane, or be engulfed and digested by a host target cell. Often used are submicron, lipid membrane artificial cells that may be referred to as nanocapsules, nanoparticles, polymersomes, or other variations of the term.\n</p>\n<h3><span class=\"mw-headline\" id=\"Enzyme_therapy\">Enzyme therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=10\" title=\"Edit section: Enzyme therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Enzyme\" title=\"Enzyme\">Enzyme</a> therapy is being actively studied for <a href=\"/wiki/Inborn_error_of_metabolism\" class=\"mw-redirect\" title=\"Inborn error of metabolism\">genetic metabolic diseases</a> where an enzyme is over-expressed, under-expressed, defective, or not at all there. In the case of under-expression or expression of a defective <a href=\"/wiki/Enzyme\" title=\"Enzyme\">enzyme</a>, an active form of the enzyme is introduced in the body to compensate for the deficit. On the other hand, an enzymatic over-expression may be counteracted by introduction of a competing non-functional enzyme; that is, an enzyme which <a href=\"/wiki/Metabolism\" title=\"Metabolism\">metabolizes</a> the substrate into non-active products. When placed within an artificial cell, enzymes can carry out their function for a much longer period compared to free enzymes<sup id=\"cite_ref-Chang_2007_1-3\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup> and can be further optimized by polymer conjugation.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p><p>The first enzyme studied under artificial cell encapsulation was <a href=\"/wiki/Asparaginase\" title=\"Asparaginase\">asparaginase</a> for the treatment of <a href=\"/wiki/Lymphosarcoma\" class=\"mw-redirect\" title=\"Lymphosarcoma\">lymphosarcoma</a> in mice. This treatment delayed the onset and growth of the <a href=\"/wiki/Tumor\" class=\"mw-redirect\" title=\"Tumor\">tumor</a>.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> These initial findings led to further research in the use of artificial cells for enzyme delivery in <a href=\"/wiki/Tyrosine\" title=\"Tyrosine\">tyrosine</a> dependent <a href=\"/wiki/Melanomas\" class=\"mw-redirect\" title=\"Melanomas\">melanomas</a>.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> These tumors have a higher dependency on <a href=\"/wiki/Tyrosine\" title=\"Tyrosine\">tyrosine</a> than normal cells for growth, and research has shown that lowering systemic levels of tyrosine in mice can inhibit growth of melanomas.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> The use of artificial cells in the delivery of <a href=\"/wiki/Tyrosinase\" title=\"Tyrosinase\">tyrosinase</a>; and enzyme that digests tyrosine, allows for better enzyme stability and is shown effective in the removal of tyrosine without the severe side-effects associated with tyrosine depravation in the diet.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>\n</p><p>Artificial cell enzyme therapy is also of interest for the activation of <a href=\"/wiki/Prodrugs\" class=\"mw-redirect\" title=\"Prodrugs\">prodrugs</a> such as <a href=\"/wiki/Ifosfamide\" title=\"Ifosfamide\">ifosfamide</a> in certain cancers. Artificial cells encapsulating the <a href=\"/wiki/Cytochrome_p450\" class=\"mw-redirect\" title=\"Cytochrome p450\">cytochrome p450</a> enzyme which converts this prodrug into the active drug can be tailored to accumulate in the pancreatic carcinoma or implanting the artificial cells close to the tumor site. Here, the local concentration of the activated ifosfamide will be much higher than in the rest of the body thus preventing systemic <a href=\"/wiki/Toxicity\" title=\"Toxicity\">toxicity</a>.<sup id=\"cite_ref-Lohr_27-0\" class=\"reference\"><a href=\"#cite_note-Lohr-27\">&#91;27&#93;</a></sup> The treatment was successful in animals<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> and showed a doubling in median survivals amongst patients with advanced-stage <a href=\"/wiki/Pancreatic_cancer\" title=\"Pancreatic cancer\">pancreatic cancer</a> in phase I/II clinical trials, and a tripling in one-year survival rate.<sup id=\"cite_ref-Lohr_27-1\" class=\"reference\"><a href=\"#cite_note-Lohr-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Gene_therapy\">Gene therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=11\" title=\"Edit section: Gene therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In treatment of genetic diseases, <a href=\"/wiki/Gene_therapy\" title=\"Gene therapy\">gene therapy</a> aims to insert, alter or remove <a href=\"/wiki/Genes\" class=\"mw-redirect\" title=\"Genes\">genes</a> within an afflicted individual's cells. The technology relies heavily on viral <a href=\"/wiki/Vector_(molecular_biology)\" title=\"Vector (molecular biology)\">vectors</a> which raises concerns about insertional <a href=\"/wiki/Mutagenesis\" title=\"Mutagenesis\">mutagenesis</a> and systemic <a href=\"/wiki/Immune_response\" title=\"Immune response\">immune response</a> that have led to human deaths<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup> and development of <a href=\"/wiki/Leukemia\" title=\"Leukemia\">leukemia</a><sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup> in clinical trials. Circumventing the need for vectors by using naked or plasmid DNA as its own delivery system also encounters problems such as low <a href=\"/wiki/Transduction_(genetics)\" title=\"Transduction (genetics)\">transduction</a> efficiency and poor tissue targeting when given systemically.<sup id=\"cite_ref-Prakash_2-4\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup>\n</p><p>Artificial cells have been proposed as a non-viral vector by which genetically modified non-autologous cells are encapsulated and implanted to deliver recombinant proteins <i>in vivo</i>.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup> This type of <a href=\"/wiki/Immunoisolate\" title=\"Immunoisolate\">immuno-isolation</a>  has been proven efficient in mice through delivery of artificial cells containing mouse <a href=\"/wiki/Growth_hormone\" title=\"Growth hormone\">growth hormone</a> which rescued a growth-retardation in mutant mice.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> A few strategies have advanced to human clinical trials for the treatment of <a href=\"/wiki/Pancreatic_cancer\" title=\"Pancreatic cancer\">pancreatic cancer</a>, lateral sclerosis and pain control.<sup id=\"cite_ref-Prakash_2-5\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Hemoperfusion\">Hemoperfusion</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=12\" title=\"Edit section: Hemoperfusion\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The first clinical use of artificial cells was in <a href=\"/wiki/Hemoperfusion\" title=\"Hemoperfusion\">hemoperfusion</a> by the encapsulation of <a href=\"/wiki/Activated_charcoal\" class=\"mw-redirect\" title=\"Activated charcoal\">activated charcoal</a>.<sup id=\"cite_ref-Chang_1996_7-1\" class=\"reference\"><a href=\"#cite_note-Chang_1996-7\">&#91;7&#93;</a></sup> Activated charcoal has the capability of adsorbing many large molecules and has for a long time been known for its ability to remove toxic substances from the blood in accidental poisoning or overdose. However, <a href=\"/wiki/Perfusion\" title=\"Perfusion\">perfusion</a> through direct charcoal administration is toxic as it leads to <a href=\"/wiki/Embolism\" title=\"Embolism\">embolisms</a> and damage of blood cells followed by removal by platelets.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup>  Artificial cells allow toxins to diffuse into the cell while keeping the dangerous cargo within their ultrathin membrane.<sup id=\"cite_ref-Chang_1996_7-2\" class=\"reference\"><a href=\"#cite_note-Chang_1996-7\">&#91;7&#93;</a></sup>\n</p><p>Artificial cell <a href=\"/wiki/Hemoperfusion\" title=\"Hemoperfusion\">hemoperfusion</a> has been proposed as a less costly and more efficient detoxifying option than <a href=\"/wiki/Hemodialysis\" title=\"Hemodialysis\">hemodialysis</a>,<sup id=\"cite_ref-Chang_2007_1-4\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup> in which blood filtering takes place only through size separation by a physical membrane.  In hemoperfusion, thousands of adsorbent artificial cells are retained inside a small container through the use of two screens on either end through which patient blood <a href=\"/wiki/Perfusion\" title=\"Perfusion\">perfuses</a>. As the blood circulates, <a href=\"/wiki/Toxins\" class=\"mw-redirect\" title=\"Toxins\">toxins</a> or drugs diffuse into the cells and are retained by the absorbing material. The membranes of artificial cells are much thinner those used in dialysis and their small size means that they have a high membrane <a href=\"/wiki/Surface_area\" title=\"Surface area\">surface area</a>. This means that a portion of cell can have a theoretical mass transfer that is a hundredfold higher than that of a whole artificial kidney machine.<sup id=\"cite_ref-Chang_2007_1-5\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup> The device has been established as a routine clinical method for patients treated for accidental or suicidal poisoning but has also been introduced as therapy in <a href=\"/wiki/Liver_failure\" title=\"Liver failure\">liver failure</a> and <a href=\"/wiki/Renal_failure\" class=\"mw-redirect\" title=\"Renal failure\">kidney failure</a> by carrying out part of the function of these organs.<sup id=\"cite_ref-Chang_2007_1-6\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup>\nArtificial cell hemoperfusion has also been proposed for use in immunoadsorption through which antibodies can be removed from the body by attaching an immunoadsorbing material such as <a href=\"/wiki/Albumin\" title=\"Albumin\">albumin</a> on the surface of the artificial cells. This principle has been used to remove <a href=\"/wiki/Blood_type\" title=\"Blood type\">blood group</a> antibodies from plasma for bone marrow transplantation<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup> and for the treatment of <a href=\"/wiki/Hypercholesterolemia\" title=\"Hypercholesterolemia\">hypercholesterolemia</a> through <a href=\"/wiki/Monoclonal_antibodies\" class=\"mw-redirect\" title=\"Monoclonal antibodies\">monoclonal antibodies</a> to remove low-density <a href=\"/wiki/Lipoproteins\" class=\"mw-redirect\" title=\"Lipoproteins\">lipoproteins</a>.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup> Hemoperfusion is especially useful in countries with a weak hemodialysis manufacturing industry as the devices tend to be cheaper there and used in <a href=\"/wiki/Renal_failure\" class=\"mw-redirect\" title=\"Renal failure\">kidney failure</a> patients.\n</p>\n<h3><span class=\"mw-headline\" id=\"Encapsulated_cells\">Encapsulated cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=13\" title=\"Edit section: Encapsulated cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:302px;\"><a href=\"/wiki/File:Cell_capsule_schematic.png\" class=\"image\"><img alt=\"Schematic of cells encapsulated within an artificial membrane.\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/27/Cell_capsule_schematic.png/300px-Cell_capsule_schematic.png\" width=\"300\" height=\"183\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/2/27/Cell_capsule_schematic.png 1.5x\" data-file-width=\"436\" data-file-height=\"266\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Cell_capsule_schematic.png\" class=\"internal\" title=\"Enlarge\"></a></div>Schematic representation of encapsulated cells within artificial membrane.</div></div></div>\n<p>The most common method of preparation of artificial cells is through <a href=\"/wiki/Cell_encapsulation\" title=\"Cell encapsulation\">cell encapsulation</a>. Encapsulated cells are typically achieved through the generation of controlled-size droplets from a liquid cell <a href=\"/wiki/Suspension_(chemistry)\" title=\"Suspension (chemistry)\">suspension</a> which are then rapidly solidified or gelated to provide added stability. The stabilization may be achieved through a change in temperature or via material crosslinking.<sup id=\"cite_ref-Prakash_2-6\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> The microenvironment that a cell sees changes upon encapsulation. It typically goes from being on a <a href=\"/wiki/Monolayer\" title=\"Monolayer\">monolayer</a> to a suspension in a polymer scaffold within a polymeric membrane. A drawback of the technique is that encapsulating a cell decreases its viability and ability to proliferate and differentiate.<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup> Further,  after some time within the microcapsule, cells form clusters that inhibit the exchange of oxygen and metabolic waste,<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup> leading to <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a> and <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a> thus limiting the efficacy of the cells and activating the host's <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune system</a>.\nArtificial cells have been successful for transplanting a number of cells including <a href=\"/wiki/Islets_of_Langerhans\" class=\"mw-redirect\" title=\"Islets of Langerhans\">islets of Langerhans</a> for <a href=\"/wiki/Type_1_diabetes\" class=\"mw-redirect\" title=\"Type 1 diabetes\">diabetes</a> treatment,<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup> <a href=\"/wiki/Parathyroid_chief_cell\" title=\"Parathyroid chief cell\">parathyroid cells</a> and adrenal cortex cells.\n</p>\n<h4><span class=\"mw-headline\" id=\"Encapsulated_hepatocytes\">Encapsulated hepatocytes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=14\" title=\"Edit section: Encapsulated hepatocytes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Shortage of organ donors make artificial cells key players in alternative therapies for <a href=\"/wiki/Liver_failure\" title=\"Liver failure\">liver failure</a>. The use of artificial cells for <a href=\"/wiki/Hepatocyte\" title=\"Hepatocyte\">hepatocyte</a> transplantation has demonstrated feasibility and efficacy in providing liver function in models of animal liver disease and <a href=\"/wiki/Bioartificial_liver_devices\" class=\"mw-redirect\" title=\"Bioartificial liver devices\">bioartificial liver devices</a>.<sup id=\"cite_ref-Dixit_41-0\" class=\"reference\"><a href=\"#cite_note-Dixit-41\">&#91;41&#93;</a></sup> Research stemmed off experiments in which the hepatocytes were attached to the surface of a micro-carriers<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> and has evolved into hepatocytes which are encapsulated in a three-dimensional matrix in <a href=\"/wiki/Alginate\" class=\"mw-redirect\" title=\"Alginate\">alginate</a> microdroplets covered by an outer skin of <a href=\"/wiki/Polylysine\" title=\"Polylysine\">polylysine</a>. A key advantage to this delivery method is the circumvention of <a href=\"/wiki/Immunosuppression\" title=\"Immunosuppression\">immunosuppression</a> therapy for the duration of the treatment. Hepatocyte encapsulations have been proposed for use in a <a href=\"/wiki/Bioartificial_liver_device\" title=\"Bioartificial liver device\">bioartifical liver</a>. The device consists of a cylindrical chamber imbedded with isolated hepatocytes through which patient plasma is circulated extra-corporeally in a type of <a href=\"/wiki/Hemoperfusion\" title=\"Hemoperfusion\">hemoperfusion</a>. Because microcapsules have a high <a href=\"/wiki/Surface_area\" title=\"Surface area\">surface area</a> to <a href=\"/wiki/Volume\" title=\"Volume\">volume</a> ratio, they provide large surface for substrate diffusion and can accommodate a large number of hepatocytes. Treatment to induced liver failure mice showed a significant increase in the rate of survival.<sup id=\"cite_ref-Dixit_41-1\" class=\"reference\"><a href=\"#cite_note-Dixit-41\">&#91;41&#93;</a></sup> Artificial liver systems are still in early development but show potential for patients waiting for <a href=\"/wiki/Organ_transplant\" class=\"mw-redirect\" title=\"Organ transplant\">organ transplant</a> or while a patient's own liver regenerates sufficiently to resume normal function. So far, clinical trials using artificial liver systems and hepatocyte transplantation in end-stage liver diseases have shown improvement of health markers but have not yet improved survival.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> The short longevity and aggregation of artificial hepatocytes after transplantation are the main obstacles encountered.\nHepatocytes co-encapsulated with <a href=\"/wiki/Stem_cells\" class=\"mw-redirect\" title=\"Stem cells\">stem cells</a> show greater viability in culture and after implantation<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup> and implantation of artificial stem cells alone have also shown liver regeneration.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup>  As such interest has arisen in the use of stem cells for encapsulation in <a href=\"/wiki/Regenerative_medicine\" title=\"Regenerative medicine\">regenerative medicine</a>.\n</p>\n<h4><span class=\"mw-headline\" id=\"Encapsulated_bacterial_cells\">Encapsulated bacterial cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=15\" title=\"Edit section: Encapsulated bacterial cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The oral ingestion of live bacterial cell <a href=\"/wiki/Colony_(biology)\" title=\"Colony (biology)\">colonies</a> has been proposed and is currently in therapy for the modulation of intestinal <a href=\"/wiki/Flora_(microbiology)\" title=\"Flora (microbiology)\">microflora</a>,<sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup> prevention of <a href=\"/wiki/Diarrheal_diseases\" class=\"mw-redirect\" title=\"Diarrheal diseases\">diarrheal diseases</a>,<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> treatment of <a href=\"/wiki/Helicobacter_pylori\" title=\"Helicobacter pylori\"><i>H. Pylori</i></a> infections, atopic inflammations,<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup> <a href=\"/wiki/Lactose_intolerance\" title=\"Lactose intolerance\">lactose intolerance</a><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup> and <a href=\"/wiki/Immune_modulation\" class=\"mw-redirect\" title=\"Immune modulation\">immune modulation</a>,<sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup> amongst others. The proposed mechanism of action is not fully understood but is believed to have two main effects. The first is the nutritional effect, in which the bacteria compete with toxin producing bacteria. The second is the sanitary effect, which stimulates resistance to colonization and stimulates <a href=\"/wiki/Immune_response\" title=\"Immune response\">immune response</a>.<sup id=\"cite_ref-Prakash_2-7\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup>  The oral delivery of bacterial cultures is often a problem because they are targeted by the immune system and often destroyed when taken orally. Artificial cells help address these issues by providing mimicry into the body and selective or long term release thus increasing the viability of bacteria reaching the <a href=\"/wiki/Gastrointestinal_system\" class=\"mw-redirect\" title=\"Gastrointestinal system\">gastrointestinal system</a>.<sup id=\"cite_ref-Prakash_2-8\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> In addition, live bacterial cell encapsulation can be engineered to allow diffusion of small molecules including peptides into the body for therapeutic purposes.<sup id=\"cite_ref-Prakash_2-9\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup>  Membranes that have proven successful for bacterial delivery include <a href=\"/wiki/Cellulose_acetate\" title=\"Cellulose acetate\">cellulose acetate</a> and variants of <a href=\"/wiki/Alginate\" class=\"mw-redirect\" title=\"Alginate\">alginate</a>.<sup id=\"cite_ref-Prakash_2-10\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> Additional uses that have arosen from encapsulation of bacterial cells include protection against challenge from <a href=\"/wiki/Mycobacterium_tuberculosis\" title=\"Mycobacterium tuberculosis\"><i>M. Tuberculosis</i></a><sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup> and upregulation of Ig secreting cells from the immune system.<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup> The technology is limited by the risk of systemic infections, adverse metabolic activities and the risk of gene transfer.<sup id=\"cite_ref-Prakash_2-11\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup> However, the greater challenge remains the delivery of sufficient viable bacteria to the site of interest.<sup id=\"cite_ref-Prakash_2-12\" class=\"reference\"><a href=\"#cite_note-Prakash-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Artificial_blood_cell\">Artificial blood cell</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=16\" title=\"Edit section: Artificial blood cell\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"Oxygen_carriers\">Oxygen carriers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=17\" title=\"Edit section: Oxygen carriers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Haemoglobin-based_oxygen_carriers\" class=\"mw-redirect\" title=\"Haemoglobin-based oxygen carriers\">Haemoglobin-based oxygen carriers</a></div>\n<p>Nano sized oxygen carriers are used as a type of <a href=\"/wiki/Red_blood_cell\" title=\"Red blood cell\">red blood cell</a> substitutes, although they lack other components of red blood cells. They are composed of a synthetic <a href=\"/wiki/Polymersome\" title=\"Polymersome\">polymersome</a> or an artificial membrane surrounding purified animal, human or recombinant <a href=\"/wiki/Hemoglobin\" title=\"Hemoglobin\">hemoglobin</a>.<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup>\nOverall, hemoglobin delivery continues to be a challenge because it is highly toxic when delivered without any modifications. In some clinical trials, vasopressor effects have been observed for first generation hemoglobin blood substitutes.<sup id=\"cite_ref-54\" class=\"reference\"><a href=\"#cite_note-54\">&#91;54&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Red_blood_cells\">Red blood cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=18\" title=\"Edit section: Red blood cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Research interest in the use of artificial cells for blood arose after the <a href=\"/wiki/AIDS\" class=\"mw-redirect\" title=\"AIDS\">AIDS</a> scare of the 1980s. Besides bypassing the potential for disease transmission, artificial red blood cells are desired because they eliminate drawbacks associated with allogenic blood transfusions such as blood typing, immune reactions and its short storage life of 42 days. A <a href=\"/wiki/Hemoglobin\" title=\"Hemoglobin\">hemoglobin</a> substitute may be stored at room temperature and not under refrigeration for more than a year.<sup id=\"cite_ref-Chang_2007_1-7\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup> Attempts have been made to develop a complete working red blood cell which comprises carbonic not only an oxygen carrier but also the enzymes associated with the cell. The first attempt was made in 1957 by replacing the red blood cell membrane by an ultrathin polymeric membrane<sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup> which was followed by encapsulation through a <a href=\"/wiki/Lipid_membrane\" class=\"mw-redirect\" title=\"Lipid membrane\">lipid membrane</a><sup id=\"cite_ref-56\" class=\"reference\"><a href=\"#cite_note-56\">&#91;56&#93;</a></sup>  and more recently a biodegradable polymeric membrane.<sup id=\"cite_ref-Chang_2007_1-8\" class=\"reference\"><a href=\"#cite_note-Chang_2007-1\">&#91;1&#93;</a></sup>\nA biological red blood cell membrane including <a href=\"/wiki/Lipids\" class=\"mw-redirect\" title=\"Lipids\">lipids</a> and associated proteins can also be used to encapsulate nanoparticles and increase residence time in vivo by bypassing <a href=\"/wiki/Macrophage\" title=\"Macrophage\">macrophage</a> uptake and systemic clearance.<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Leuko-polymersome\">Leuko-polymersome</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=19\" title=\"Edit section: Leuko-polymersome\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>A leuko-polymersome is a <a href=\"/wiki/Polymersome\" title=\"Polymersome\">polymersome</a> engineered to have the adhesive properties of a <a href=\"/wiki/Leukocyte\" class=\"mw-redirect\" title=\"Leukocyte\">leukocyte</a>.<sup id=\"cite_ref-58\" class=\"reference\"><a href=\"#cite_note-58\">&#91;58&#93;</a></sup> Polymersomes are vesicles composed of a bilayer sheet that can encapsulate many active molecules such as drugs or <a href=\"/wiki/Enzymes\" class=\"mw-redirect\" title=\"Enzymes\">enzymes</a>. By adding the adhesive properties of a leukocyte to their membranes, they can be made to slow down, or roll along epithelial walls within the quickly flowing <a href=\"/wiki/Circulatory_system\" title=\"Circulatory system\">circulatory system</a>.\n</p>\n<h2><span class=\"mw-headline\" id=\"Synthetic_cells\">Synthetic cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=20\" title=\"Edit section: Synthetic cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"The_minimal_cell\">The minimal cell</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=21\" title=\"Edit section: The minimal cell\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The German pathologist <a href=\"/wiki/Rudolf_Virchow\" title=\"Rudolf Virchow\">Rudolf Virchow</a> brought forward the idea that not only does life arise from cells, but every cell comes from another cell;  \"<i>Omnis cellula e cellula</i>\".<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup> Until now, most attempts to create an artificial cell have only created a package that can mimic certain tasks of the cell. Advances in cell-free <a href=\"/wiki/Transcription_(genetics)\" class=\"mw-redirect\" title=\"Transcription (genetics)\">transcription</a> and <a href=\"/wiki/Translation_(biology)\" title=\"Translation (biology)\">translation</a> reactions allow the expression of many <a href=\"/wiki/Genes\" class=\"mw-redirect\" title=\"Genes\">genes</a>, but these efforts are far from producing a fully operational cell.\n</p><p>The future is in the creation of a <a href=\"/wiki/Protocell\" title=\"Protocell\">protocell</a>, or a cell which has all the minimum requirements for life. Members from the <a href=\"/wiki/J._Craig_Venter_Institute\" title=\"J. Craig Venter Institute\">J. Craig Venter Institute</a> have used a <a href=\"/wiki/Top-down_and_bottom-up_design\" title=\"Top-down and bottom-up design\">top-down</a> computational approach to knock out genes in a living organism to a minimum set of genes.<sup id=\"cite_ref-gibson52_5-1\" class=\"reference\"><a href=\"#cite_note-gibson52-5\">&#91;5&#93;</a></sup> In 2010, the team succeeded in creating a replicating strain of <i><a href=\"/wiki/Mycoplasma_mycoides\" title=\"Mycoplasma mycoides\">Mycoplasma mycoides</a></i> (<a href=\"/wiki/Mycoplasma_laboratorium\" title=\"Mycoplasma laboratorium\">Mycoplasma laboratorium</a>) using synthetically created DNA deemed to be the minimum requirement for life which was inserted into a genomically empty bacterium.<sup id=\"cite_ref-gibson52_5-2\" class=\"reference\"><a href=\"#cite_note-gibson52-5\">&#91;5&#93;</a></sup> It is hoped that the process of top-down biosynthesis will enable the insertion of new genes that would perform profitable functions such as generation of hydrogen for fuel or capturing excess carbon dioxide in the atmosphere.<sup id=\"cite_ref-Beadau_60-0\" class=\"reference\"><a href=\"#cite_note-Beadau-60\">&#91;60&#93;</a></sup>  the myriad regulatory, metabolic, and signaling networks are not completely characterized. These <a href=\"/wiki/Top-down_and_bottom-up_design\" title=\"Top-down and bottom-up design\">top-down</a> approaches have limitations for the understanding of fundamental molecular regulation, since the host organisms have a complex and incompletely defined molecular composition.<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup>\n</p><p>A <a href=\"/wiki/Top-down_and_bottom-up_design\" title=\"Top-down and bottom-up design\">bottom-up</a> approach to build an artificial cell would involve creating a protocell <i>de novo</i>, entirely from non-living materials. It is proposed to create a <a href=\"/wiki/Phospholipid_bilayer\" class=\"mw-redirect\" title=\"Phospholipid bilayer\">phospholipid bilayer</a> vesicle with DNA capable of self-reproducing using synthetic genetic information. The three primary elements of such artificial cells are the formation of a <a href=\"/wiki/Lipid_membrane\" class=\"mw-redirect\" title=\"Lipid membrane\">lipid membrane</a>, <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> and <a href=\"/wiki/RNA\" title=\"RNA\">RNA</a> replication through a template process and the harvesting of chemical energy for <a href=\"/wiki/Active_transport\" title=\"Active transport\">active transport</a> across the membrane.<sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup><sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup> The main hurdles foreseen and encountered with this proposed protocell are the creation of a minimal synthetic DNA that holds all sufficient information for life, and the reproduction of non-genetic components that are integral in cell development such as molecular self-organization.<sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup> However, it is hoped that this kind of bottom-up approach would provide insight into the fundamental questions of organizations at the cellular level and the origins of biological life. So far, no completely artificial cell capable of self-reproduction has been synthesized using the molecules of life, and this objective is still in a distant future although various groups are currently working towards this goal.<sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup>\n</p><p>Another method proposed to create a protocell more closely resembles the <a href=\"/wiki/RNA_world_hypothesis\" class=\"mw-redirect\" title=\"RNA world hypothesis\">conditions</a> believed to have been present during evolution known as the primordial soup. Various RNA polymers could be encapsulated in vesicles and in such small boundary conditions, chemical reactions would be tested for.<sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup>\n</p><p>Heavy investing in biology has been done by large companies such as <a href=\"/wiki/ExxonMobil\" title=\"ExxonMobil\">ExxonMobil</a>, who has partnered with <a href=\"/wiki/Synthetic_Genomics\" class=\"mw-redirect\" title=\"Synthetic Genomics\">Synthetic Genomics Inc</a>; Craig Venter's own biosynthetics company in the development of fuel from algae.<sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Electronic_artificial_cell\">Electronic artificial cell</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=22\" title=\"Edit section: Electronic artificial cell\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The concept of an Electronic Artificial Cell has been expanded in a series of 3 EU projects coordinated by John McCaskill from 2004-2015.\n</p><p>The <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a> sponsored the development of the <a rel=\"nofollow\" class=\"external text\" href=\"http://www.istpace.org//index.html\">\"Programmable Artificial Cell Evolution\" (PACE)</a> program from 2004-2008 whose goal was to lay the foundation for the creation of \"microscopic self-organizing, self-replicating, and evolvable autonomous entities built from simple organic and inorganic substances that can be genetically programmed to perform specific functions\"<sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup> for the eventual integration into information systems. The PACE project developed the first Omega Machine, a microfluidic life support system for artificial cells that could complement chemically missing functionalities (as originally proposed by Norman Packard, Steen Rasmussen, Mark Beadau and John McCaskill). The ultimate aim was to attain an evolvable hybrid cell in a complex microscale programmable environment. The functions of the Omega Machine could then be removed stepwise, posing a series of solvable evolution challenges to the artificial cell chemistry. The project achieved chemical integration up to the level of pairs of the three core functions of artificial cells (a genetic subsystem, a containment system and a metabolic system), and generated novel spatially resolved programmable microfluidic environments for the integration of containment and genetic amplification.<a rel=\"nofollow\" class=\"external text\" href=\"http://www.istpace.org//index.html\">\"Programmable Artificial Cell Evolution\" (PACE)</a>  The project led to the creation of the <a rel=\"nofollow\" class=\"external autonumber\" href=\"https://web.archive.org/web/20111214010917/http://www.ecltech.org/ecltech_j/\">[1]</a> European center for living technology] which is now continuing similar research.\n</p><p>Following this research, in 2007, John McCaskill proposed to concentrate on an electronically complemented artificial cell, called the <b>Electronic Chemical Cell</b>. The key idea was to use a massively parallel array of electrodes coupled to locally dedicated electronic circuitry, in a two-dimensional thin film, to complement emerging chemical cellular functionality. Local electronic information defining the electrode switching and sensing circuits could serve as an electronic genome, complementing the molecular sequential information in the emerging protocols. A research proposal was successful with the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a> and an international team of scientists partially overlapping with the PACE consortium commenced work 2008-2012 on the project Electronic Chemical Cells. The project demonstrated among other things that electronically controlled local transport of specific sequences could be used as an artificial spatial control system for the genetic proliferation of future artificial cells, and that core processes of metabolism could be delivered by suitably coated electrode arrays.\n</p><p>The major limitation of this approach, apart from the initial difficulties in mastering microscale electrochemistry and electrokinetics, is that the electronic system is interconnected as a rigid non-autonomous piece of macroscopic hardware. In 2011, McCaskill proposed to invert the geometry of electronics and chemistry&#160;: instead of placing chemicals in an active electronic medium, to place microscopic autonomous electronics in a chemical medium. He organized a project to tackle a third generation of Electronic Artificial Cells at the 100&#160;\u00b5m scale that could self-assemble from two half-cells \"lablets\" to enclose an internal chemical space, and function with the aid of active electronics powered by the medium they are immersed in. Such cells can copy both their electronic and chemical contents and will be capable of evolution within the constraints provided by their special pre-synthesized microscopic building blocks. In Sep 2012 work commenced on this project <a rel=\"nofollow\" class=\"external text\" href=\"http://www.MICREAgents.eu/\">Microscale Chemically Reactive Electronic Agents</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Ethics_and_controversy\">Ethics and controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=23\" title=\"Edit section: Ethics and controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Protocell research has created controversy and opposing opinions, including critics of the vague definition of \"artificial life\".<sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup>  The creation of a basic unit of life is the most pressing ethical concern, although the most widespread worry about protocells is their potential threat to human health and the environment through uncontrolled replication.<sup id=\"cite_ref-Beadau_60-1\" class=\"reference\"><a href=\"#cite_note-Beadau-60\">&#91;60&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=24\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Chemoton\" title=\"Chemoton\">Chemoton</a></li>\n<li><a href=\"/wiki/Jeewanu\" title=\"Jeewanu\">Jeewanu</a></li>\n<li><a href=\"/wiki/Protocell\" title=\"Protocell\">Protocell</a></li>\n<li><a href=\"/wiki/Synthetic_biology\" title=\"Synthetic biology\">Synthetic biology</a></li>\n<li><a href=\"/wiki/Targeted_drug_delivery\" title=\"Targeted drug delivery\">Targeted drug delivery</a></li>\n<li><a href=\"/wiki/Respirocyte\" title=\"Respirocyte\">Respirocyte</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=25\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Chang_2007-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Chang_2007_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Chang_2007_1-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Chang, Thomas Ming Swi (2007). <i>Artificial cells&#160;: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy</i>. Hackensack, N.J.: World Scientific. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/981-270-576-7\" title=\"Special:BookSources/981-270-576-7\">981-270-576-7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Artificial+cells+%3A+biotechnology%2C+nanomedicine%2C+regenerative+medicine%2C+blood+substitutes%2C+bioencapsulation%2C+cell%2Fstem+cell+therapy&amp;rft.place=Hackensack%2C+N.J.&amp;rft.pub=World+Scientific&amp;rft.date=2007&amp;rft.isbn=981-270-576-7&amp;rft.aulast=Chang&amp;rft.aufirst=Thomas+Ming+Swi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prakash-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prakash_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Prakash_2-12\"><sup><i><b>m</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Prakash, S. (2007). <i>Artificial cells, cell engineering and therapy</i>. Boca Raton, Fl: Woodhead Publishing Limited. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-84569-036-6\" title=\"Special:BookSources/978-1-84569-036-6\">978-1-84569-036-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Artificial+cells%2C+cell+engineering+and+therapy.&amp;rft.place=Boca+Raton%2C+Fl&amp;rft.pub=Woodhead+Publishing+Limited&amp;rft.date=2007&amp;rft.isbn=978-1-84569-036-6&amp;rft.aulast=Prakash&amp;rft.aufirst=S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Gebelein, Charles G. (1983). <i>Polymeric materials and artificial organs based on a symposium sponsored by the Division of Organic Coatings and Plastics Chemistry at the 185th Meeting of the American Chemical Society</i>. Washington, D.C.: American Chemical Society. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-8412-1084-4\" title=\"Special:BookSources/978-0-8412-1084-4\">978-0-8412-1084-4</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Polymeric+materials+and+artificial+organs+based+on+a+symposium+sponsored+by+the+Division+of+Organic+Coatings+and+Plastics+Chemistry+at+the+185th+Meeting+of+the+American+Chemical+Society&amp;rft.place=Washington%2C+D.C.&amp;rft.pub=American+Chemical+Society&amp;rft.date=1983&amp;rft.isbn=978-0-8412-1084-4&amp;rft.aulast=Gebelein&amp;rft.aufirst=Charles+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Deamer, D (July 2005). \"A giant step towards artificial life?\". <i>Trends in Biotechnology</i>. <b>23</b> (7): 336\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.tibtech.2005.05.008\">10.1016/j.tibtech.2005.05.008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15935500\">15935500</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Biotechnology&amp;rft.atitle=A+giant+step+towards+artificial+life%3F&amp;rft.volume=23&amp;rft.issue=7&amp;rft.pages=336-8&amp;rft.date=2005-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tibtech.2005.05.008&amp;rft_id=info%3Apmid%2F15935500&amp;rft.aulast=Deamer&amp;rft.aufirst=D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-gibson52-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gibson52_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gibson52_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gibson52_5-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gibson, D. G.; Glass, J. I.; Lartigue, C.; Noskov, V. N.; Chuang, R.-Y.; Algire, M. A.; Benders, G. A.; Montague, M. G.; Ma, L.; Moodie, M. M.; Merryman, C.; Vashee, S.; Krishnakumar, R.; Assad-Garcia, N.; Andrews-Pfannkoch, C.; Denisova, E. A.; Young, L.; Qi, Z.-Q.; Segall-Shapiro, T. H.; Calvey, C. H.; Parmar, P. P.; Hutchison, C. A.; Smith, H. O.; Venter, J. C. (20 May 2010). \"Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome\". <i>Science</i>. <b>329</b> (5987): 52\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1190719\">10.1126/science.1190719</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20488990\">20488990</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Creation+of+a+Bacterial+Cell+Controlled+by+a+Chemically+Synthesized+Genome&amp;rft.volume=329&amp;rft.issue=5987&amp;rft.pages=52-56&amp;rft.date=2010-05-20&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1190719&amp;rft_id=info%3Apmid%2F20488990&amp;rft.aulast=Gibson&amp;rft.aufirst=D.+G.&amp;rft.au=Glass%2C+J.+I.&amp;rft.au=Lartigue%2C+C.&amp;rft.au=Noskov%2C+V.+N.&amp;rft.au=Chuang%2C+R.-Y.&amp;rft.au=Algire%2C+M.+A.&amp;rft.au=Benders%2C+G.+A.&amp;rft.au=Montague%2C+M.+G.&amp;rft.au=Ma%2C+L.&amp;rft.au=Moodie%2C+M.+M.&amp;rft.au=Merryman%2C+C.&amp;rft.au=Vashee%2C+S.&amp;rft.au=Krishnakumar%2C+R.&amp;rft.au=Assad-Garcia%2C+N.&amp;rft.au=Andrews-Pfannkoch%2C+C.&amp;rft.au=Denisova%2C+E.+A.&amp;rft.au=Young%2C+L.&amp;rft.au=Qi%2C+Z.-Q.&amp;rft.au=Segall-Shapiro%2C+T.+H.&amp;rft.au=Calvey%2C+C.+H.&amp;rft.au=Parmar%2C+P.+P.&amp;rft.au=Hutchison%2C+C.+A.&amp;rft.au=Smith%2C+H.+O.&amp;rft.au=Venter%2C+J.+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chang, TM (1964). \"Semipermeable microscapsules\". <i>Science</i>. <b>146</b> (3643): 524\u2013525. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.146.3643.524\">10.1126/science.146.3643.524</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14190240\">14190240</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Semipermeable+microscapsules.&amp;rft.volume=146&amp;rft.issue=3643&amp;rft.pages=524-525&amp;rft.date=1964&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.146.3643.524&amp;rft_id=info%3Apmid%2F14190240&amp;rft.aulast=Chang&amp;rft.aufirst=TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Chang_1996-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Chang_1996_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Chang_1996_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Chang_1996_7-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chang, T.M.S (1996). \"Editorial: past, present and future perspectives on the 40th anniversary of hemoglobin based red blood cell substitutes\". <i>Artificial Cells Blood Substit Immobil Biotechnol</i>. <b>24</b>: ixxxvi.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+Cells+Blood+Substit+Immobil+Biotechnol&amp;rft.atitle=Editorial%3A+past%2C+present+and+future+perspectives+on+the+40th+anniversary+of+hemoglobin+based+red+blood+cell+substitutes&amp;rft.volume=24&amp;rft.pages=ixxxvi&amp;rft.date=1996&amp;rft.aulast=Chang&amp;rft.aufirst=T.M.S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Palmour, RM; Goodyer, P; Reade, T; Chang, TM (16 September 1989). \"Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan disease\". <i>Lancet</i>. <b>2</b> (8664): 687\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0140-6736%2889%2990939-2\">10.1016/s0140-6736(89)90939-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2570944\">2570944</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Microencapsulated+xanthine+oxidase+as+experimental+therapy+in+Lesch-Nyhan+disease.&amp;rft.volume=2&amp;rft.issue=8664&amp;rft.pages=687-8&amp;rft.date=1989-09-16&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2889%2990939-2&amp;rft_id=info%3Apmid%2F2570944&amp;rft.aulast=Palmour&amp;rft.aufirst=RM&amp;rft.au=Goodyer%2C+P&amp;rft.au=Reade%2C+T&amp;rft.au=Chang%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Chang, Thomas Ming (1997). <i>Blood substitutes</i>. Basel: Karger. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/3-8055-6584-4\" title=\"Special:BookSources/3-8055-6584-4\">3-8055-6584-4</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Blood+substitutes&amp;rft.place=Basel&amp;rft.pub=Karger&amp;rft.date=1997&amp;rft.isbn=3-8055-6584-4&amp;rft.aulast=Chang&amp;rft.aufirst=Thomas+Ming&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Soon-Shiong, P.; Heintz, R.E.; Merideth, N.; Yao, Q.X.; Yao, Z.; Zheng, T.; Murphy, M.; Moloney, M.K.; Schmehl, M.; Harris, M.; Mendez, R.; Mendez, R.; Sandford, P.A. (1 April 1994). \"Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation\". <i>The Lancet</i>. <b>343</b> (8903): 950\u2013951. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2894%2990067-1\">10.1016/S0140-6736(94)90067-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Insulin+independence+in+a+type+1+diabetic+patient+after+encapsulated+islet+transplantation&amp;rft.volume=343&amp;rft.issue=8903&amp;rft.pages=950-951&amp;rft.date=1994-04-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2894%2990067-1&amp;rft.aulast=Soon-Shiong&amp;rft.aufirst=P.&amp;rft.au=Heintz%2C+R.E.&amp;rft.au=Merideth%2C+N.&amp;rft.au=Yao%2C+Q.X.&amp;rft.au=Yao%2C+Z.&amp;rft.au=Zheng%2C+T.&amp;rft.au=Murphy%2C+M.&amp;rft.au=Moloney%2C+M.K.&amp;rft.au=Schmehl%2C+M.&amp;rft.au=Harris%2C+M.&amp;rft.au=Mendez%2C+R.&amp;rft.au=Mendez%2C+R.&amp;rft.au=Sandford%2C+P.A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Liu, ZC; Chang, TM (June 2003). \"Coencapsulation of hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo lowering of bilirubin in hyperbilirubemia Gunn rats\". <i>The International Journal of Artificial Organs</i>. <b>26</b> (6): 491\u20137. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12894754\">12894754</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+International+Journal+of+Artificial+Organs&amp;rft.atitle=Coencapsulation+of+hepatocytes+and+bone+marrow+stem+cells%3A+in+vitro+conversion+of+ammonia+and+in+vivo+lowering+of+bilirubin+in+hyperbilirubemia+Gunn+rats.&amp;rft.volume=26&amp;rft.issue=6&amp;rft.pages=491-7&amp;rft.date=2003-06&amp;rft_id=info%3Apmid%2F12894754&amp;rft.aulast=Liu&amp;rft.aufirst=ZC&amp;rft.au=Chang%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Aebischer, Patrick; Schluep, Myriam; D\u00e9glon, Nicole; Joseph, Jean-Marc; Hirt, Lorenz; Heyd, Bruno; Goddard, Moses; Hammang, Joseph P.; Zurn, Anne D.; Kato, Ann C.; Regli, Franco; Baetge, E. Edward (1 June 1996). \"Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients\". <i>Nature Medicine</i>. <b>2</b> (6): 696\u2013699. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nm0696-696\">10.1038/nm0696-696</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8640564\">8640564</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=Intrathecal+delivery+of+CNTF+using+encapsulated+genetically+modifiedxenogeneic+cells+in+amyotrophic+lateral+sclerosis+patients&amp;rft.volume=2&amp;rft.issue=6&amp;rft.pages=696-699&amp;rft.date=1996-06-01&amp;rft_id=info%3Adoi%2F10.1038%2Fnm0696-696&amp;rft_id=info%3Apmid%2F8640564&amp;rft.aulast=Aebischer&amp;rft.aufirst=Patrick&amp;rft.au=Schluep%2C+Myriam&amp;rft.au=D%C3%A9glon%2C+Nicole&amp;rft.au=Joseph%2C+Jean-Marc&amp;rft.au=Hirt%2C+Lorenz&amp;rft.au=Heyd%2C+Bruno&amp;rft.au=Goddard%2C+Moses&amp;rft.au=Hammang%2C+Joseph+P.&amp;rft.au=Zurn%2C+Anne+D.&amp;rft.au=Kato%2C+Ann+C.&amp;rft.au=Regli%2C+Franco&amp;rft.au=Baetge%2C+E.+Edward&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-JACS-20111229-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-JACS-20111229_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Budin, Itay; Devaraj, Neal K. (29 December 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://pubs.acs.org/doi/abs/10.1021/ja2076873\">\"Membrane Assembly Driven by a Biomimetic Coupling Reaction\"</a>. <i><a href=\"/wiki/Journal_of_the_American_Chemical_Society\" title=\"Journal of the American Chemical Society\">Journal of the American Chemical Society</a></i>. <b>134</b> (2): 751\u2013753. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/ja2076873\">10.1021/ja2076873</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3262119\">3262119</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Chemical+Society&amp;rft.atitle=Membrane+Assembly+Driven+by+a+Biomimetic+Coupling+Reaction&amp;rft.volume=134&amp;rft.issue=2&amp;rft.pages=751-753&amp;rft.date=2011-12-29&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3262119&amp;rft_id=info%3Adoi%2F10.1021%2Fja2076873&amp;rft.aulast=Budin&amp;rft.aufirst=Itay&amp;rft.au=Devaraj%2C+Neal+K.&amp;rft_id=http%3A%2F%2Fpubs.acs.org%2Fdoi%2Fabs%2F10.1021%2Fja2076873&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SD-20120125-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-SD-20120125_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Staff (25 January 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedaily.com/releases/2012/01/120125132822.htm\">\"Chemists Synthesize Artificial Cell Membrane\"</a>. <a href=\"/wiki/ScienceDaily\" class=\"mw-redirect\" title=\"ScienceDaily\">ScienceDaily</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Chemists+Synthesize+Artificial+Cell+Membrane&amp;rft.pub=ScienceDaily&amp;rft.date=2012-01-25&amp;rft.au=Staff&amp;rft_id=https%3A%2F%2Fwww.sciencedaily.com%2Freleases%2F2012%2F01%2F120125132822.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-KZ-20120126-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-KZ-20120126_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Staff (26 January 2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.kurzweilai.net/chemists-create-artificial-cell-membrane\">\"Chemists create artificial cell membrane\"</a>. <a href=\"/wiki/Ray_Kurzweil\" title=\"Ray Kurzweil\">kurzweilai.net</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Chemists+create+artificial+cell+membrane&amp;rft.pub=kurzweilai.net&amp;rft.date=2012-01-26&amp;rft.au=Staff&amp;rft_id=http%3A%2F%2Fwww.kurzweilai.net%2Fchemists-create-artificial-cell-membrane&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.gizmag.com/first-plastic-artificial-cell-working-organelles/30460/\">\"World-first working eukaryotic cell made from plastic\"</a>. Gizmag.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-01-17</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=World-first+working+eukaryotic+cell+made+from+plastic&amp;rft.pub=Gizmag.com&amp;rft_id=http%3A%2F%2Fwww.gizmag.com%2Ffirst-plastic-artificial-cell-working-organelles%2F30460%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johnson, R. (2013). \"Nanoreactors: Catalysis in compartments\". <i>Nature Chemistry</i>. <b>6</b>: 5. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nchem.1840\">10.1038/nchem.1840</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Chemistry&amp;rft.atitle=Nanoreactors%3A+Catalysis+in+compartments&amp;rft.volume=6&amp;rft.pages=5&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1038%2Fnchem.1840&amp;rft.aulast=Johnson&amp;rft.aufirst=R.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://healthunlocked.com/blf/posts/138847986/artificial-cells-are-tiny-bacteria-fighters.\">\"Artificial Cells Are Tiny Bacteria Fighters. - British Lung Foundation | HealthUnlocked\"</a>. <i>HealthUnlocked</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-09-07</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=HealthUnlocked&amp;rft.atitle=Artificial+Cells+Are+Tiny+Bacteria+Fighters.+-+British+Lung+Foundation+%7C+HealthUnlocked&amp;rft_id=https%3A%2F%2Fhealthunlocked.com%2Fblf%2Fposts%2F138847986%2Fartificial-cells-are-tiny-bacteria-fighters.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.firstpost.com/tech/science/researchers-create-artificial-lego-cells-that-can-detect-and-fight-bacteria-5108011.html\">\"Researchers create artificial 'lego cells' that can detect and fight bacteria- Technology News, Firstpost\"</a>. <i>Tech2</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-09-07</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Tech2&amp;rft.atitle=Researchers+create+artificial+%27lego+cells%27+that+can+detect+and+fight+bacteria-+Technology+News%2C+Firstpost&amp;rft_id=https%3A%2F%2Fwww.firstpost.com%2Ftech%2Fscience%2Fresearchers-create-artificial-lego-cells-that-can-detect-and-fight-bacteria-5108011.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedaily.com/releases/2018/09/180904093733.htm\">\"Artificial cells are tiny bacteria fighters\"</a>. <i>ScienceDaily</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-09-07</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ScienceDaily&amp;rft.atitle=Artificial+cells+are+tiny+bacteria+fighters&amp;rft_id=https%3A%2F%2Fwww.sciencedaily.com%2Freleases%2F2018%2F09%2F180904093733.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vivier, A; Vuillemard, JC; Ackermann, HW; Poncelet, D (1992). \"Large-scale blood substitute production using a microfluidizer\". <i>Biomaterials, Artificial Cells, and Immobilization Biotechnology</i>. <b>20</b> (2\u20134): 377\u201397. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/10731199209119658\">10.3109/10731199209119658</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1391454\">1391454</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biomaterials%2C+Artificial+Cells%2C+and+Immobilization+Biotechnology&amp;rft.atitle=Large-scale+blood+substitute+production+using+a+microfluidizer&amp;rft.volume=20&amp;rft.issue=2%E2%80%934&amp;rft.pages=377-97&amp;rft.date=1992&amp;rft_id=info%3Adoi%2F10.3109%2F10731199209119658&amp;rft_id=info%3Apmid%2F1391454&amp;rft.aulast=Vivier&amp;rft.aufirst=A&amp;rft.au=Vuillemard%2C+JC&amp;rft.au=Ackermann%2C+HW&amp;rft.au=Poncelet%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\">Park et al 1981</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chang, TM (8 January 1971). \"The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma\". <i>Nature</i>. <b>229</b> (5280): 117\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/229117a0\">10.1038/229117a0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4923094\">4923094</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=The+in+vivo+effects+of+semipermeable+microcapsules+containing+L-asparaginase+on+6C3HED+lymphosarcoma.&amp;rft.volume=229&amp;rft.issue=5280&amp;rft.pages=117-8&amp;rft.date=1971-01-08&amp;rft_id=info%3Adoi%2F10.1038%2F229117a0&amp;rft_id=info%3Apmid%2F4923094&amp;rft.aulast=Chang&amp;rft.aufirst=TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yu, B; Chang, TM (April 2004). \"Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in rats\". <i>Journal of Pharmaceutical Sciences</i>. <b>93</b> (4): 831\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jps.10593\">10.1002/jps.10593</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14999721\">14999721</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pharmaceutical+Sciences&amp;rft.atitle=Effects+of+long-term+oral+administration+of+polymeric+microcapsules+containing+tyrosinase+on+maintaining+decreased+systemic+tyrosine+levels+in+rats.&amp;rft.volume=93&amp;rft.issue=4&amp;rft.pages=831-7&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1002%2Fjps.10593&amp;rft_id=info%3Apmid%2F14999721&amp;rft.aulast=Yu&amp;rft.aufirst=B&amp;rft.au=Chang%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Meadows, GG; Pierson, HF; Abdallah, RM; Desai, PR (August 1982). \"Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy\". <i>Cancer Research</i>. <b>42</b> (8): 3056\u201363. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7093952\">7093952</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Dietary+influence+of+tyrosine+and+phenylalanine+on+the+response+of+B16+melanoma+to+carbidopa-levodopa+methyl+ester+chemotherapy.&amp;rft.volume=42&amp;rft.issue=8&amp;rft.pages=3056-63&amp;rft.date=1982-08&amp;rft_id=info%3Apmid%2F7093952&amp;rft.aulast=Meadows&amp;rft.aufirst=GG&amp;rft.au=Pierson%2C+HF&amp;rft.au=Abdallah%2C+RM&amp;rft.au=Desai%2C+PR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chang, TM (February 2004). \"Artificial cell bioencapsulation in macro, micro, nano, and molecular dimensions: keynote lecture\". <i>Artificial cells, blood substitutes, and immobilization biotechnology</i>. <b>32</b> (1): 1\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1081/bio-120028665\">10.1081/bio-120028665</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15027798\">15027798</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+cells%2C+blood+substitutes%2C+and+immobilization+biotechnology&amp;rft.atitle=Artificial+cell+bioencapsulation+in+macro%2C+micro%2C+nano%2C+and+molecular+dimensions%3A+keynote+lecture.&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=1-23&amp;rft.date=2004-02&amp;rft_id=info%3Adoi%2F10.1081%2Fbio-120028665&amp;rft_id=info%3Apmid%2F15027798&amp;rft.aulast=Chang&amp;rft.aufirst=TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Lohr-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lohr_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lohr_27-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">L\u00f6hr M, Hummel F, Faulmann G, Ringel J, Saller R, Hain J, G\u00fcnzburg WH, Salmons B (2002). \"Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor; the magic bullets of the 21st century\". <i>Cancer Chemother Pharmacol</i>. <b>49</b>: S21\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00280-002-0448-0\">10.1007/s00280-002-0448-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12042985\">12042985</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Chemother+Pharmacol&amp;rft.atitle=Microencapsulated%2C+CYP2B1-transfected+cells+activating+ifosfamide+at+the+site+of+the+tumor%3B+the+magic+bullets+of+the+21st+century&amp;rft.volume=49&amp;rft.pages=S21-24&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1007%2Fs00280-002-0448-0&amp;rft_id=info%3Apmid%2F12042985&amp;rft.aulast=L%C3%B6hr&amp;rft.aufirst=M&amp;rft.au=Hummel%2C+F&amp;rft.au=Faulmann%2C+G&amp;rft.au=Ringel%2C+J&amp;rft.au=Saller%2C+R&amp;rft.au=Hain%2C+J&amp;rft.au=G%C3%BCnzburg%2C+WH&amp;rft.au=Salmons%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kr\u00f6ger JC, Benz S, Hoffmeyer A, Bago Z, Bergmeister H, G\u00fcnzburg WH, Karle P, Kl\u00f6ppel G, Losert U, M\u00fcller P, Nizze H, Obermaier R, Probst A, Renner M, Saller R, Salmons B, Schwendenwein I, von Rombs K, Wiessner R, Wagner T, Hauenstein K, L\u00f6hr M (1999). \"Intraarterial instillation of microencapsulated cells in the pancreatic arteries in pig\". <i>Annals of the New York Academy of Sciences</i>. <b>3</b> (1): 55\u201363. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1159/000069147\">10.1159/000069147</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12649565\">12649565</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&amp;rft.atitle=Intraarterial+instillation+of+microencapsulated+cells+in+the+pancreatic+arteries+in+pig&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=55-63&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1159%2F000069147&amp;rft_id=info%3Apmid%2F12649565&amp;rft.aulast=Kr%C3%B6ger&amp;rft.aufirst=JC&amp;rft.au=Benz%2C+S&amp;rft.au=Hoffmeyer%2C+A&amp;rft.au=Bago%2C+Z&amp;rft.au=Bergmeister%2C+H&amp;rft.au=G%C3%BCnzburg%2C+WH&amp;rft.au=Karle%2C+P&amp;rft.au=Kl%C3%B6ppel%2C+G&amp;rft.au=Losert%2C+U&amp;rft.au=M%C3%BCller%2C+P&amp;rft.au=Nizze%2C+H&amp;rft.au=Obermaier%2C+R&amp;rft.au=Probst%2C+A&amp;rft.au=Renner%2C+M&amp;rft.au=Saller%2C+R&amp;rft.au=Salmons%2C+B&amp;rft.au=Schwendenwein%2C+I&amp;rft.au=von+Rombs%2C+K&amp;rft.au=Wiessner%2C+R&amp;rft.au=Wagner%2C+T&amp;rft.au=Hauenstein%2C+K&amp;rft.au=L%C3%B6hr%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carmen, I (1 April 2001). \"A Death in the Laboratory: The Politics of the Gelsinger Aftermath\". <i>Molecular Therapy</i>. <b>3</b> (4): 425\u2013428. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1006/mthe.2001.0305\">10.1006/mthe.2001.0305</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11319902\">11319902</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Therapy&amp;rft.atitle=A+Death+in+the+Laboratory%3A+The+Politics+of+the+Gelsinger+Aftermath&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=425-428&amp;rft.date=2001-04-01&amp;rft_id=info%3Adoi%2F10.1006%2Fmthe.2001.0305&amp;rft_id=info%3Apmid%2F11319902&amp;rft.aulast=Carmen&amp;rft.aufirst=I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML (1 September 2003). \"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer\". <i>Molecular Genetics and Metabolism</i>. <b>80</b> (1\u20132): 148\u2013158. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ymgme.2003.08.016\">10.1016/j.ymgme.2003.08.016</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14567964\">14567964</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Genetics+and+Metabolism&amp;rft.atitle=Fatal+systemic+inflammatory+response+syndrome+in+a+ornithine+transcarbamylase+deficient+patient+following+adenoviral+gene+transfer&amp;rft.volume=80&amp;rft.issue=1%E2%80%932&amp;rft.pages=148-158&amp;rft.date=2003-09-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ymgme.2003.08.016&amp;rft_id=info%3Apmid%2F14567964&amp;rft.aulast=Chirmule&amp;rft.aufirst=N&amp;rft.au=Lee%2C+FS&amp;rft.au=Wivel%2C+NA&amp;rft.au=Bagg%2C+A&amp;rft.au=Gao%2C+GP&amp;rft.au=Wilson%2C+JM&amp;rft.au=Batshaw%2C+ML&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cavazzana-Calvo, M.; Hacein-Bey, S; De Saint Basile, G; Gross, F; Yvon, E; Nusbaum, P; Selz, F; Hue, C; Certain, S; Casanova, J. L.; Bousso, P; Deist, F. L.; Fischer, A (28 April 2000). \"Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease\". <i>Science</i>. <b>288</b> (5466): 669\u2013672. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.288.5466.669\">10.1126/science.288.5466.669</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10784449\">10784449</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Gene+Therapy+of+Human+Severe+Combined+Immunodeficiency+%28SCID%29-X1+Disease&amp;rft.volume=288&amp;rft.issue=5466&amp;rft.pages=669-672&amp;rft.date=2000-04-28&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.288.5466.669&amp;rft_id=info%3Apmid%2F10784449&amp;rft.aulast=Cavazzana-Calvo&amp;rft.aufirst=M.&amp;rft.au=Hacein-Bey%2C+S&amp;rft.au=De+Saint+Basile%2C+G&amp;rft.au=Gross%2C+F&amp;rft.au=Yvon%2C+E&amp;rft.au=Nusbaum%2C+P&amp;rft.au=Selz%2C+F&amp;rft.au=Hue%2C+C&amp;rft.au=Certain%2C+S&amp;rft.au=Casanova%2C+J.+L.&amp;rft.au=Bousso%2C+P&amp;rft.au=Deist%2C+F.+L.&amp;rft.au=Fischer%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hacein-Bey-Abina, S.; von Kalle, C; Schmidt, M; McCormack, M. P.; Wulffraat, N; Leboulch, P; Lim, A; Osborne, C. S.; Pawliuk, R; Morillon, E; Sorensen, R; Forster, A; Fraser, P; Cohen, J. I.; De Saint Basile, G; Alexander, I; Wintergerst, U; Frebourg, T; Aurias, A; Stoppa-Lyonnet, D; Romana, S; Radford-Weiss, I; Gross, F; Valensi, F; Delabesse, E; MacIntyre, E; Sigaux, F; Soulier, J; Leiva, L. E.;  et al. (17 October 2003). \"LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1\". <i>Science</i>. <b>302</b> (5644): 415\u2013419. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1088547\">10.1126/science.1088547</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14564000\">14564000</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=LMO2-Associated+Clonal+T+Cell+Proliferation+in+Two+Patients+after+Gene+Therapy+for+SCID-X1&amp;rft.volume=302&amp;rft.issue=5644&amp;rft.pages=415-419&amp;rft.date=2003-10-17&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1088547&amp;rft_id=info%3Apmid%2F14564000&amp;rft.aulast=Hacein-Bey-Abina&amp;rft.aufirst=S.&amp;rft.au=von+Kalle%2C+C&amp;rft.au=Schmidt%2C+M&amp;rft.au=McCormack%2C+M.+P.&amp;rft.au=Wulffraat%2C+N&amp;rft.au=Leboulch%2C+P&amp;rft.au=Lim%2C+A&amp;rft.au=Osborne%2C+C.+S.&amp;rft.au=Pawliuk%2C+R&amp;rft.au=Morillon%2C+E&amp;rft.au=Sorensen%2C+R&amp;rft.au=Forster%2C+A&amp;rft.au=Fraser%2C+P&amp;rft.au=Cohen%2C+J.+I.&amp;rft.au=De+Saint+Basile%2C+G&amp;rft.au=Alexander%2C+I&amp;rft.au=Wintergerst%2C+U&amp;rft.au=Frebourg%2C+T&amp;rft.au=Aurias%2C+A&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Romana%2C+S&amp;rft.au=Radford-Weiss%2C+I&amp;rft.au=Gross%2C+F&amp;rft.au=Valensi%2C+F&amp;rft.au=Delabesse%2C+E&amp;rft.au=MacIntyre%2C+E&amp;rft.au=Sigaux%2C+F&amp;rft.au=Soulier%2C+J&amp;rft.au=Leiva%2C+L.+E.&amp;rft.au=Wissler%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chang, P; Van Raamsdonk, J. M.; Hortelano, G; Barsoum, S. C.; MacDonald, N. C.; Stockley, T. L. (1 February 1999). \"The in vivo delivery of heterologous proteins by microencapsulated recombinant cells\". <i>Trends in Biotechnology</i>. <b>17</b> (2): 78\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0167-7799%2898%2901250-5\">10.1016/S0167-7799(98)01250-5</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10087608\">10087608</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Biotechnology&amp;rft.atitle=The+in+vivo+delivery+of+heterologous+proteins+by+microencapsulated+recombinant+cells&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=78-83&amp;rft.date=1999-02-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0167-7799%2898%2901250-5&amp;rft_id=info%3Apmid%2F10087608&amp;rft.aulast=Chang&amp;rft.aufirst=P&amp;rft.au=Van+Raamsdonk%2C+J.+M.&amp;rft.au=Hortelano%2C+G&amp;rft.au=Barsoum%2C+S.+C.&amp;rft.au=MacDonald%2C+N.+C.&amp;rft.au=Stockley%2C+T.+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Al-Hendy, Ayman; Hortelano, Gonzalo; Tannenbaum, Gloria S.; Chang, Patricia L. (1 February 1995). \"Correction of the Growth Defect in Dwarf Mice with Nonautologous Microencapsulated Myoblasts\u2014An Alternate Approach to Somatic Gene Therapy\". <i>Human Gene Therapy</i>. <b>6</b> (2): 165\u2013175. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1089/hum.1995.6.2-165\">10.1089/hum.1995.6.2-165</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7734517\">7734517</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Gene+Therapy&amp;rft.atitle=Correction+of+the+Growth+Defect+in+Dwarf+Mice+with+Nonautologous+Microencapsulated+Myoblasts%E2%80%94An+Alternate+Approach+to+Somatic+Gene+Therapy&amp;rft.volume=6&amp;rft.issue=2&amp;rft.pages=165-175&amp;rft.date=1995-02-01&amp;rft_id=info%3Adoi%2F10.1089%2Fhum.1995.6.2-165&amp;rft_id=info%3Apmid%2F7734517&amp;rft.aulast=Al-Hendy&amp;rft.aufirst=Ayman&amp;rft.au=Hortelano%2C+Gonzalo&amp;rft.au=Tannenbaum%2C+Gloria+S.&amp;rft.au=Chang%2C+Patricia+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">DUNEA, G; KOLFF, WJ (1965). \"CLINICAL EXPERIENCE WITH THE YATZIDIS CHARCOAL ARTIFICIAL KIDNEY\". <i>Transactions - American Society for Artificial Internal Organs</i>. <b>11</b>: 178\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00002480-196504000-00035\">10.1097/00002480-196504000-00035</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14329080\">14329080</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transactions+-+American+Society+for+Artificial+Internal+Organs&amp;rft.atitle=CLINICAL+EXPERIENCE+WITH+THE+YATZIDIS+CHARCOAL+ARTIFICIAL+KIDNEY.&amp;rft.volume=11&amp;rft.pages=178-82&amp;rft.date=1965&amp;rft_id=info%3Adoi%2F10.1097%2F00002480-196504000-00035&amp;rft_id=info%3Apmid%2F14329080&amp;rft.aulast=DUNEA&amp;rft.aufirst=G&amp;rft.au=KOLFF%2C+WJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bensinger, WI; Buckner, CD; Clift, RA (1985). \"Whole blood immunoadsorption of anti-A or anti-B antibodies\". <i>Vox sanguinis</i>. <b>48</b> (6): 357\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1423-0410.1985.tb00196.x\">10.1111/j.1423-0410.1985.tb00196.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3892895\">3892895</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vox+sanguinis&amp;rft.atitle=Whole+blood+immunoadsorption+of+anti-A+or+anti-B+antibodies.&amp;rft.volume=48&amp;rft.issue=6&amp;rft.pages=357-61&amp;rft.date=1985&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1423-0410.1985.tb00196.x&amp;rft_id=info%3Apmid%2F3892895&amp;rft.aulast=Bensinger&amp;rft.aufirst=WI&amp;rft.au=Buckner%2C+CD&amp;rft.au=Clift%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang, L; Cheng, Y; Yan, WR; Yu, YT (2004). \"Extracorporeal whole blood immunoadsorption of autoimmune myasthenia gravis by cellulose tryptophan adsorbent\". <i>Artificial cells, blood substitutes, and immobilization biotechnology</i>. <b>32</b> (4): 519\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1081/bio-200039610\">10.1081/bio-200039610</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15974179\">15974179</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+cells%2C+blood+substitutes%2C+and+immobilization+biotechnology&amp;rft.atitle=Extracorporeal+whole+blood+immunoadsorption+of+autoimmune+myasthenia+gravis+by+cellulose+tryptophan+adsorbent.&amp;rft.volume=32&amp;rft.issue=4&amp;rft.pages=519-28&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1081%2Fbio-200039610&amp;rft_id=info%3Apmid%2F15974179&amp;rft.aulast=Yang&amp;rft.aufirst=L&amp;rft.au=Cheng%2C+Y&amp;rft.au=Yan%2C+WR&amp;rft.au=Yu%2C+YT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\">In Wolff, J.A., (editor), Chang, M.T.S. et al (1994) Calcium phosphate-mediated DNA transfection. <i>Gene Therapeutics</i> Boston, Birkhauser Boston, Inc.</span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ponce, S; Orive, G; Gasc\u00f3n, AR; Hern\u00e1ndez, RM; Pedraz, JL (11 April 2005). \"Microcapsules prepared with different biomaterials to immobilize GDNF secreting 3T3 fibroblasts\". <i>International journal of pharmaceutics</i>. <b>293</b> (1\u20132): 1\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ijpharm.2004.10.028\">10.1016/j.ijpharm.2004.10.028</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15778039\">15778039</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+journal+of+pharmaceutics&amp;rft.atitle=Microcapsules+prepared+with+different+biomaterials+to+immobilize+GDNF+secreting+3T3+fibroblasts&amp;rft.volume=293&amp;rft.issue=1%E2%80%932&amp;rft.pages=1-10&amp;rft.date=2005-04-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ijpharm.2004.10.028&amp;rft_id=info%3Apmid%2F15778039&amp;rft.aulast=Ponce&amp;rft.aufirst=S&amp;rft.au=Orive%2C+G&amp;rft.au=Gasc%C3%B3n%2C+AR&amp;rft.au=Hern%C3%A1ndez%2C+RM&amp;rft.au=Pedraz%2C+JL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kizilel, Seda; Garfinkel, Marc; Opara, Emmanuel (1 December 2005). \"The Bioartificial Pancreas: Progress and Challenges\". <i>Diabetes Technology &amp; Therapeutics</i>. <b>7</b> (6): 968\u2013985. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1089/dia.2005.7.968\">10.1089/dia.2005.7.968</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16386103\">16386103</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+Technology+%26+Therapeutics&amp;rft.atitle=The+Bioartificial+Pancreas%3A+Progress+and+Challenges&amp;rft.volume=7&amp;rft.issue=6&amp;rft.pages=968-985&amp;rft.date=2005-12-01&amp;rft_id=info%3Adoi%2F10.1089%2Fdia.2005.7.968&amp;rft_id=info%3Apmid%2F16386103&amp;rft.aulast=Kizilel&amp;rft.aufirst=Seda&amp;rft.au=Garfinkel%2C+Marc&amp;rft.au=Opara%2C+Emmanuel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Dixit-41\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Dixit_41-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Dixit_41-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dixit, Vivek; Gitnick, Gary (27 November 2003). \"The bioartificial liver: state-of-the-art\". <i>European Journal of Surgery</i>. <b>164</b> (S12): 71\u201376. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1080/11024159850191481\">10.1080/11024159850191481</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Surgery&amp;rft.atitle=The+bioartificial+liver%3A+state-of-the-art&amp;rft.volume=164&amp;rft.issue=S12&amp;rft.pages=71-76&amp;rft.date=2003-11-27&amp;rft_id=info%3Adoi%2F10.1080%2F11024159850191481&amp;rft.aulast=Dixit&amp;rft.aufirst=Vivek&amp;rft.au=Gitnick%2C+Gary&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\">Demetriou 1986</span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sgroi, A; Serre-Beinier, V; Morel, P; B\u00fchler, L (27 February 2009). \"What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation\". <i>Transplantation</i>. <b>87</b> (4): 457\u201366. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/TP.0b013e3181963ad3\">10.1097/TP.0b013e3181963ad3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19307780\">19307780</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transplantation&amp;rft.atitle=What+clinical+alternatives+to+whole+liver+transplantation%3F+Current+status+of+artificial+devices+and+hepatocyte+transplantation.&amp;rft.volume=87&amp;rft.issue=4&amp;rft.pages=457-66&amp;rft.date=2009-02-27&amp;rft_id=info%3Adoi%2F10.1097%2FTP.0b013e3181963ad3&amp;rft_id=info%3Apmid%2F19307780&amp;rft.aulast=Sgroi&amp;rft.aufirst=A&amp;rft.au=Serre-Beinier%2C+V&amp;rft.au=Morel%2C+P&amp;rft.au=B%C3%BChler%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Liu, ZC; Chang, TM (March 2002). \"Increased viability of transplanted hepatocytes when hepatocytes are co-encapsulated with bone marrow stem cells using a novel method\". <i>Artificial cells, blood substitutes, and immobilization biotechnology</i>. <b>30</b> (2): 99\u2013112. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1081/bio-120003191\">10.1081/bio-120003191</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12027231\">12027231</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+cells%2C+blood+substitutes%2C+and+immobilization+biotechnology&amp;rft.atitle=Increased+viability+of+transplanted+hepatocytes+when+hepatocytes+are+co-encapsulated+with+bone+marrow+stem+cells+using+a+novel+method.&amp;rft.volume=30&amp;rft.issue=2&amp;rft.pages=99-112&amp;rft.date=2002-03&amp;rft_id=info%3Adoi%2F10.1081%2Fbio-120003191&amp;rft_id=info%3Apmid%2F12027231&amp;rft.aulast=Liu&amp;rft.aufirst=ZC&amp;rft.au=Chang%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Orive, edited by Jos\u00e9 Luis Pedraz, Gorka (2010). <i>Therapeutic applications of cell microencapsulation</i> (Online-Ausg. ed.). New York: Springer Science+Business Media. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-4419-5785-6\" title=\"Special:BookSources/978-1-4419-5785-6\">978-1-4419-5785-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Therapeutic+applications+of+cell+microencapsulation&amp;rft.place=New+York&amp;rft.edition=Online-Ausg.&amp;rft.pub=Springer+Science%2BBusiness+Media&amp;rft.date=2010&amp;rft.isbn=978-1-4419-5785-6&amp;rft.aulast=Orive&amp;rft.aufirst=edited+by+Jos%C3%A9+Luis+Pedraz%2C+Gorka&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Extra text: authors list (<a href=\"/wiki/Category:CS1_maint:_Extra_text:_authors_list\" title=\"Category:CS1 maint: Extra text: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mattila-Sandholm, T; Blum, S.; Collins, J.K.; Crittenden, R.; De Vos, W.; Dunne, C.; Fond\u00e9n, R.; Grenov, G.; Isolauri, E.; Kiely, B.; Marteau, P.; Morelli, L.; Ouwehand, A.; Reniero, R.; Saarela, M.; Salminen, S.; Saxelin, M.; Schiffrin, E.; Shanahan, F.; Vaughan, E.; von Wright, A. (1 December 1999). \"Probiotics: towards demonstrating efficacy\". <i>Trends in Food Science &amp; Technology</i>. <b>10</b> (12): 393\u2013399. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0924-2244%2800%2900029-7\">10.1016/S0924-2244(00)00029-7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Food+Science+%26+Technology&amp;rft.atitle=Probiotics%3A+towards+demonstrating+efficacy&amp;rft.volume=10&amp;rft.issue=12&amp;rft.pages=393-399&amp;rft.date=1999-12-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0924-2244%2800%2900029-7&amp;rft.aulast=Mattila-Sandholm&amp;rft.aufirst=T&amp;rft.au=Blum%2C+S.&amp;rft.au=Collins%2C+J.K.&amp;rft.au=Crittenden%2C+R.&amp;rft.au=De+Vos%2C+W.&amp;rft.au=Dunne%2C+C.&amp;rft.au=Fond%C3%A9n%2C+R.&amp;rft.au=Grenov%2C+G.&amp;rft.au=Isolauri%2C+E.&amp;rft.au=Kiely%2C+B.&amp;rft.au=Marteau%2C+P.&amp;rft.au=Morelli%2C+L.&amp;rft.au=Ouwehand%2C+A.&amp;rft.au=Reniero%2C+R.&amp;rft.au=Saarela%2C+M.&amp;rft.au=Salminen%2C+S.&amp;rft.au=Saxelin%2C+M.&amp;rft.au=Schiffrin%2C+E.&amp;rft.au=Shanahan%2C+F.&amp;rft.au=Vaughan%2C+E.&amp;rft.au=von+Wright%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Huang, JS; Bousvaros, A; Lee, JW; Diaz, A; Davidson, EJ (November 2002). \"Efficacy of probiotic use in acute diarrhea in children: a meta-analysis\". <i>Digestive Diseases and Sciences</i>. <b>47</b> (11): 2625\u201334. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12452406\">12452406</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+Diseases+and+Sciences&amp;rft.atitle=Efficacy+of+probiotic+use+in+acute+diarrhea+in+children%3A+a+meta-analysis.&amp;rft.volume=47&amp;rft.issue=11&amp;rft.pages=2625-34&amp;rft.date=2002-11&amp;rft_id=info%3Apmid%2F12452406&amp;rft.aulast=Huang&amp;rft.aufirst=JS&amp;rft.au=Bousvaros%2C+A&amp;rft.au=Lee%2C+JW&amp;rft.au=Diaz%2C+A&amp;rft.au=Davidson%2C+EJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Isolauri, E; Arvola, T; S\u00fctas, Y; Moilanen, E; Salminen, S (November 2000). \"Probiotics in the management of atopic eczema\". <i>Clinical and Experimental Allergy</i>. <b>30</b> (11): 1604\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1046/j.1365-2222.2000.00943.x\">10.1046/j.1365-2222.2000.00943.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11069570\">11069570</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+and+Experimental+Allergy&amp;rft.atitle=Probiotics+in+the+management+of+atopic+eczema.&amp;rft.volume=30&amp;rft.issue=11&amp;rft.pages=1604-10&amp;rft.date=2000-11&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2222.2000.00943.x&amp;rft_id=info%3Apmid%2F11069570&amp;rft.aulast=Isolauri&amp;rft.aufirst=E&amp;rft.au=Arvola%2C+T&amp;rft.au=S%C3%BCtas%2C+Y&amp;rft.au=Moilanen%2C+E&amp;rft.au=Salminen%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lin, MY; Yen, CL; Chen, SH (January 1998). \"Management of lactose maldigestion by consuming milk containing lactobacilli\". <i>Digestive Diseases and Sciences</i>. <b>43</b> (1): 133\u20137. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9508514\">9508514</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+Diseases+and+Sciences&amp;rft.atitle=Management+of+lactose+maldigestion+by+consuming+milk+containing+lactobacilli.&amp;rft.volume=43&amp;rft.issue=1&amp;rft.pages=133-7&amp;rft.date=1998-01&amp;rft_id=info%3Apmid%2F9508514&amp;rft.aulast=Lin&amp;rft.aufirst=MY&amp;rft.au=Yen%2C+CL&amp;rft.au=Chen%2C+SH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gill, H.S. (1 May 1998). \"Stimulation of the Immune System by Lactic Cultures\". <i>International Dairy Journal</i>. <b>8</b> (5\u20136): 535\u2013544. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0958-6946%2898%2900074-0\">10.1016/S0958-6946(98)00074-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Dairy+Journal&amp;rft.atitle=Stimulation+of+the+Immune+System+by+Lactic+Cultures&amp;rft.volume=8&amp;rft.issue=5%E2%80%936&amp;rft.pages=535-544&amp;rft.date=1998-05-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0958-6946%2898%2900074-0&amp;rft.aulast=Gill&amp;rft.aufirst=H.S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Aldwell, F. E.; Tucker, I. G.; de Lisle, G. W.; Buddle, B. M. (1 January 2003). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC143408\">\"Oral Delivery of Mycobacterium bovis BCG in a Lipid Formulation Induces Resistance to Pulmonary Tuberculosis in Mice\"</a>. <i>Infection and Immunity</i>. <b>71</b> (1): 101\u2013108. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/IAI.71.1.101-108.2003\">10.1128/IAI.71.1.101-108.2003</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC143408\">143408</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12496154\">12496154</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection+and+Immunity&amp;rft.atitle=Oral+Delivery+of+Mycobacterium+bovis+BCG+in+a+Lipid+Formulation+Induces+Resistance+to+Pulmonary+Tuberculosis+in+Mice&amp;rft.volume=71&amp;rft.issue=1&amp;rft.pages=101-108&amp;rft.date=2003-01-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC143408&amp;rft_id=info%3Apmid%2F12496154&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.71.1.101-108.2003&amp;rft.aulast=Aldwell&amp;rft.aufirst=F.+E.&amp;rft.au=Tucker%2C+I.+G.&amp;rft.au=de+Lisle%2C+G.+W.&amp;rft.au=Buddle%2C+B.+M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC143408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Park JH, Um JI, Lee BJ, Goh JS, Park SY, Kim WS, Kim PH (September 2002). \"Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production\". <i>Cellular immunology</i>. <b>219</b> (1): 22\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0008-8749%2802%2900579-8\">10.1016/S0008-8749(02)00579-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12473264\">12473264</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cellular+immunology&amp;rft.atitle=Encapsulated+Bifidobacterium+bifidum+potentiates+intestinal+IgA+production&amp;rft.volume=219&amp;rft.issue=1&amp;rft.pages=22-7&amp;rft.date=2002-09&amp;rft_id=info%3Adoi%2F10.1016%2FS0008-8749%2802%2900579-8&amp;rft_id=info%3Apmid%2F12473264&amp;rft.aulast=Park&amp;rft.aufirst=JH&amp;rft.au=Um%2C+JI&amp;rft.au=Lee%2C+BJ&amp;rft.au=Goh%2C+JS&amp;rft.au=Park%2C+SY&amp;rft.au=Kim%2C+WS&amp;rft.au=Kim%2C+PH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kim, HW; Greenburg, AG (September 2004). \"Artificial oxygen carriers as red blood cell substitutes: a selected review and current status\". <i>Artificial Organs</i>. <b>28</b> (9): 813\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1525-1594.2004.07345.x\">10.1111/j.1525-1594.2004.07345.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15320945\">15320945</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+Organs&amp;rft.atitle=Artificial+oxygen+carriers+as+red+blood+cell+substitutes%3A+a+selected+review+and+current+status.&amp;rft.volume=28&amp;rft.issue=9&amp;rft.pages=813-28&amp;rft.date=2004-09&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-1594.2004.07345.x&amp;rft_id=info%3Apmid%2F15320945&amp;rft.aulast=Kim&amp;rft.aufirst=HW&amp;rft.au=Greenburg%2C+AG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-54\">^</a></b></span> <span class=\"reference-text\">Nelson 1998, Burhop and Estep 2001</span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"30th Anniversary in Artificial Red Blood Cell Research\". <i>Artificial Cells, Blood Substitutes and Biotechnology</i>. <b>16</b> (1\u20133): 1\u20139. 1 January 1988. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/10731198809132551\">10.3109/10731198809132551</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+Cells%2C+Blood+Substitutes+and+Biotechnology&amp;rft.atitle=30th+Anniversary+in+Artificial+Red+Blood+Cell+Research&amp;rft.volume=16&amp;rft.issue=1%E2%80%933&amp;rft.pages=1-9&amp;rft.date=1988-01-01&amp;rft_id=info%3Adoi%2F10.3109%2F10731198809132551&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-56\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Djordjevich, L; Miller, IF (May 1980). \"Synthetic erythrocytes from lipid encapsulated hemoglobin\". <i>Experimental hematology</i>. <b>8</b> (5): 584\u201392. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7461058\">7461058</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Experimental+hematology&amp;rft.atitle=Synthetic+erythrocytes+from+lipid+encapsulated+hemoglobin.&amp;rft.volume=8&amp;rft.issue=5&amp;rft.pages=584-92&amp;rft.date=1980-05&amp;rft_id=info%3Apmid%2F7461058&amp;rft.aulast=Djordjevich&amp;rft.aufirst=L&amp;rft.au=Miller%2C+IF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hu, CM; Zhang, L; Aryal, S; Cheung, C; Fang, RH; Zhang, L (5 July 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131364\">\"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>108</b> (27): 10980\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1106634108\">10.1073/pnas.1106634108</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131364\">3131364</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21690347\">21690347</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Erythrocyte+membrane-camouflaged+polymeric+nanoparticles+as+a+biomimetic+delivery+platform.&amp;rft.volume=108&amp;rft.issue=27&amp;rft.pages=10980-5&amp;rft.date=2011-07-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3131364&amp;rft_id=info%3Apmid%2F21690347&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1106634108&amp;rft.aulast=Hu&amp;rft.aufirst=CM&amp;rft.au=Zhang%2C+L&amp;rft.au=Aryal%2C+S&amp;rft.au=Cheung%2C+C&amp;rft.au=Fang%2C+RH&amp;rft.au=Zhang%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3131364&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hammer, Daniel A.; Robbins, Gregory P.; Haun, Jered B.; Lin, John J.; Qi, Wei; Smith, Lee A.; Peter Ghoroghchian, P.; Therien, Michael J.; Bates, Frank S. (1 January 2008). \"Leuko-polymersomes\". <i>Faraday Discussions</i>. <b>139</b>: 129. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1039/B717821B\">10.1039/B717821B</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Faraday+Discussions&amp;rft.atitle=Leuko-polymersomes&amp;rft.volume=139&amp;rft.pages=129&amp;rft.date=2008-01-01&amp;rft_id=info%3Adoi%2F10.1039%2FB717821B&amp;rft.aulast=Hammer&amp;rft.aufirst=Daniel+A.&amp;rft.au=Robbins%2C+Gregory+P.&amp;rft.au=Haun%2C+Jered+B.&amp;rft.au=Lin%2C+John+J.&amp;rft.au=Qi%2C+Wei&amp;rft.au=Smith%2C+Lee+A.&amp;rft.au=Peter+Ghoroghchian%2C+P.&amp;rft.au=Therien%2C+Michael+J.&amp;rft.au=Bates%2C+Frank+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\">Virchow RLK (1858) Die cellularpathologie in ihrer begr\u00fcndung auf physiologische und pathologische gewebelehre (A. Hirschwald, Berlin) p xv</span>\n</li>\n<li id=\"cite_note-Beadau-60\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Beadau_60-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Beadau_60-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Parke, Emily C. (2009).  Beadau, Mark A., ed. <i>The ethics of protocells moral and social implications of creating life in the laboratory</i> ([Online-Ausg.] ed.). Cambridge, Mass.: MIT Press. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-262-51269-5\" title=\"Special:BookSources/978-0-262-51269-5\">978-0-262-51269-5</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+ethics+of+protocells+moral+and+social+implications+of+creating+life+in+the+laboratory&amp;rft.place=Cambridge%2C+Mass.&amp;rft.edition=%5BOnline-Ausg.%5D&amp;rft.pub=MIT+Press&amp;rft.date=2009&amp;rft.isbn=978-0-262-51269-5&amp;rft.au=Parke%2C+Emily+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Armstrong, Rachel (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mdpi.com/2075-1729/4/3/457/htm\">\"Nanoporous Silica-Based Protocells at Multiple Scales for Designs of Life and Nanomedicine\"</a>. <i>Life</i>. <b>4</b> (3): 457\u2013490. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/life4030457\">10.3390/life4030457</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-04-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Life&amp;rft.atitle=Nanoporous+Silica-Based+Protocells+at+Multiple+Scales+for+Designs+of+Life+and+Nanomedicine&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=457-490&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.3390%2Flife4030457&amp;rft.aulast=Armstrong&amp;rft.aufirst=Rachel&amp;rft_id=http%3A%2F%2Fwww.mdpi.com%2F2075-1729%2F4%2F3%2F457%2Fhtm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Szostak, Jack W.; Bartel, David P.; Luisi, P. Luigi (18 January 2001). \"Synthesizing life\". <i>Nature</i>. <b>409</b> (6818): 387\u2013390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/35053176\">10.1038/35053176</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11201752\">11201752</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Synthesizing+life&amp;rft.volume=409&amp;rft.issue=6818&amp;rft.pages=387-390&amp;rft.date=2001-01-18&amp;rft_id=info%3Adoi%2F10.1038%2F35053176&amp;rft_id=info%3Apmid%2F11201752&amp;rft.aulast=Szostak&amp;rft.aufirst=Jack+W.&amp;rft.au=Bartel%2C+David+P.&amp;rft.au=Luisi%2C+P.+Luigi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pohorille, Andrew; Deamer, David (1 March 2002). \"Artificial cells: prospects for biotechnology\". <i>Trends in Biotechnology</i>. <b>20</b> (3): 123\u2013128. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0167-7799%2802%2901909-1\">10.1016/S0167-7799(02)01909-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11841864\">11841864</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Biotechnology&amp;rft.atitle=Artificial+cells%3A+prospects+for+biotechnology&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=123-128&amp;rft.date=2002-03-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0167-7799%2802%2901909-1&amp;rft_id=info%3Apmid%2F11841864&amp;rft.aulast=Pohorille&amp;rft.aufirst=Andrew&amp;rft.au=Deamer%2C+David&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Noireaux, V; Maeda, YT; Libchaber, A (1 March 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3048108\">\"Development of an artificial cell, from self-organization to computation and self-reproduction\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>108</b> (9): 3473\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1017075108\">10.1073/pnas.1017075108</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3048108\">3048108</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21317359\">21317359</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Development+of+an+artificial+cell%2C+from+self-organization+to+computation+and+self-reproduction.&amp;rft.volume=108&amp;rft.issue=9&amp;rft.pages=3473-80&amp;rft.date=2011-03-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3048108&amp;rft_id=info%3Apmid%2F21317359&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1017075108&amp;rft.aulast=Noireaux&amp;rft.aufirst=V&amp;rft.au=Maeda%2C+YT&amp;rft.au=Libchaber%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3048108&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rasmussen, S; Chen, L; Nilsson, M; Abe, S (Summer 2003). \"Bridging nonliving and living matter\". <i>Artificial Life</i>. <b>9</b> (3): 269\u2013316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1162/106454603322392479\">10.1162/106454603322392479</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14556688\">14556688</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+Life&amp;rft.atitle=Bridging+nonliving+and+living+matter.&amp;rft.ssn=summer&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=269-316&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1162%2F106454603322392479&amp;rft_id=info%3Apmid%2F14556688&amp;rft.aulast=Rasmussen&amp;rft.aufirst=S&amp;rft.au=Chen%2C+L&amp;rft.au=Nilsson%2C+M&amp;rft.au=Abe%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gilbert, Walter (20 February 1986). \"Origin of life: The RNA world\". <i>Nature</i>. <b>319</b> (6055): 618\u2013618. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/319618a0\">10.1038/319618a0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Origin+of+life%3A+The+RNA+world&amp;rft.volume=319&amp;rft.issue=6055&amp;rft.pages=618-618&amp;rft.date=1986-02-20&amp;rft_id=info%3Adoi%2F10.1038%2F319618a0&amp;rft.aulast=Gilbert&amp;rft.aufirst=Walter&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sheridan, C (September 2009). \"Big oil bucks for algae\". <i>Nature Biotechnology</i>. <b>27</b> (9): 783. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt0909-783\">10.1038/nbt0909-783</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19741613\">19741613</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Big+oil+bucks+for+algae.&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=783&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt0909-783&amp;rft_id=info%3Apmid%2F19741613&amp;rft.aulast=Sheridan&amp;rft.aufirst=C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\">PACE report</span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bedau, M; Church, G; Rasmussen, S; Caplan, A; Benner, S; Fussenegger, M; Collins, J; Deamer, D (27 May 2010). \"Life after the synthetic cell\". <i>Nature</i>. <b>465</b> (7297): 422\u2013424. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/465422a\">10.1038/465422a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20495545\">20495545</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Life+after+the+synthetic+cell&amp;rft.volume=465&amp;rft.issue=7297&amp;rft.pages=422-424&amp;rft.date=2010-05-27&amp;rft_id=info%3Adoi%2F10.1038%2F465422a&amp;rft_id=info%3Apmid%2F20495545&amp;rft.aulast=Bedau&amp;rft.aufirst=M&amp;rft.au=Church%2C+G&amp;rft.au=Rasmussen%2C+S&amp;rft.au=Caplan%2C+A&amp;rft.au=Benner%2C+S&amp;rft.au=Fussenegger%2C+M&amp;rft.au=Collins%2C+J&amp;rft.au=Deamer%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AArtificial+cell\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Artificial_cell&amp;action=edit&amp;section=26\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.informahealthcare.com/abb\">Artificial Cells, Blood Substitutes, and Biotechnology</a> Journal of <i>Artificial Cells Blood Substitutes and Biotechnology</i></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2203\nCached time: 20180921014220\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.892 seconds\nReal time usage: 0.928 seconds\nPreprocessor visited node count: 3553/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 126986/2097152 bytes\nTemplate argument size: 96/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 93410/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.500/10.000 seconds\nLua memory usage: 3.46 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  697.217      1 -total\n 94.09%  656.044      1 Template:Reflist\n 61.48%  428.640     51 Template:Cite_journal\n 10.71%   74.666      6 Template:Cite_book\n  3.86%   26.905      1 Template:Main\n  3.37%   23.493      4 Template:Cite_web\n  1.96%   13.689      2 Template:Cite_news\n  0.35%    2.440      1 Template:Main_other\n  0.23%    1.593      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:4630125-0!canonical and timestamp 20180921014220 and revision id 860494655\n -->\n</div>"},"langlinks":[{"lang":"es","url":"https://es.wikipedia.org/wiki/C%C3%A9lula_artificial","langname":"Spanish","autonym":"espa\u00f1ol","*":"C\u00e9lula artificial"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Cellule_artificielle","langname":"French","autonym":"fran\u00e7ais","*":"Cellule artificielle"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EC%9D%B8%EA%B3%B5_%EC%84%B8%ED%8F%AC","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\uc778\uacf5 \uc138\ud3ec"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Cellula_artificiale","langname":"Italian","autonym":"italiano","*":"Cellula artificiale"},{"lang":"lv","url":"https://lv.wikipedia.org/wiki/M%C4%81ksl%C4%ABga_%C5%A1%C5%ABna","langname":"Latvian","autonym":"latvie\u0161u","*":"M\u0101ksl\u012bga \u0161\u016bna"},{"lang":"hu","url":"https://hu.wikipedia.org/wiki/Mesters%C3%A9ges_sejt_(biol%C3%B3gia)","langname":"Hungarian","autonym":"magyar","*":"Mesters\u00e9ges sejt (biol\u00f3gia)"},{"lang":"ta","url":"https://ta.wikipedia.org/wiki/%E0%AE%9A%E0%AF%86%E0%AE%AF%E0%AE%B1%E0%AF%8D%E0%AE%95%E0%AF%88_%E0%AE%89%E0%AE%AF%E0%AE%BF%E0%AE%B0%E0%AE%A3%E0%AF%81","langname":"Tamil","autonym":"\u0ba4\u0bae\u0bbf\u0bb4\u0bcd","*":"\u0b9a\u0bc6\u0baf\u0bb1\u0bcd\u0b95\u0bc8 \u0b89\u0baf\u0bbf\u0bb0\u0ba3\u0bc1"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%A8%D1%82%D1%83%D1%87%D0%BD%D0%B0_%D0%BA%D0%BB%D1%96%D1%82%D0%B8%D0%BD%D0%B0","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u0428\u0442\u0443\u0447\u043d\u0430 \u043a\u043b\u0456\u0442\u0438\u043d\u0430"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Extra_text:_authors_list"},{"sortkey":"","*":"Cell_biology"},{"sortkey":"","*":"Emerging_technologies"},{"sortkey":"","*":"Synthetic_biology"}],"links":[{"ns":0,"exists":"","*":"AIDS"},{"ns":0,"exists":"","*":"Activated charcoal"},{"ns":0,"exists":"","*":"Active transport"},{"ns":0,"exists":"","*":"Adsorption"},{"ns":0,"exists":"","*":"Albumin"},{"ns":0,"exists":"","*":"Alginate"},{"ns":0,"exists":"","*":"Alginic acid"},{"ns":0,"exists":"","*":"Antigens"},{"ns":0,"exists":"","*":"Apoptosis"},{"ns":0,"exists":"","*":"Asparaginase"},{"ns":0,"exists":"","*":"Bioartificial liver device"},{"ns":0,"exists":"","*":"Bioartificial liver devices"},{"ns":0,"exists":"","*":"Biocompatibility"},{"ns":0,"exists":"","*":"Blood type"},{"ns":0,"exists":"","*":"Cell (biology)"},{"ns":0,"exists":"","*":"Cell encapsulation"},{"ns":0,"exists":"","*":"Cell membrane"},{"ns":0,"exists":"","*":"Cellulose"},{"ns":0,"exists":"","*":"Cellulose acetate"},{"ns":0,"exists":"","*":"Chemoton"},{"ns":0,"exists":"","*":"Circulatory system"},{"ns":0,"exists":"","*":"Collodion"},{"ns":0,"exists":"","*":"Colony (biology)"},{"ns":0,"exists":"","*":"Cytochrome p450"},{"ns":0,"exists":"","*":"Cytoplasm"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"Diarrheal diseases"},{"ns":0,"exists":"","*":"Diffusion"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Drug delivery"},{"ns":0,"exists":"","*":"Electrochemical gradient"},{"ns":0,"exists":"","*":"Embolism"},{"ns":0,"exists":"","*":"Emulsion"},{"ns":0,"exists":"","*":"Energy"},{"ns":0,"exists":"","*":"Enzyme"},{"ns":0,"exists":"","*":"Enzymes"},{"ns":0,"exists":"","*":"Eukaryotic cell"},{"ns":0,"exists":"","*":"European Commission"},{"ns":0,"exists":"","*":"ExxonMobil"},{"ns":0,"exists":"","*":"Flora (microbiology)"},{"ns":0,"exists":"","*":"Gastrointestinal system"},{"ns":0,"exists":"","*":"Gene therapy"},{"ns":0,"exists":"","*":"Genes"},{"ns":0,"exists":"","*":"Genome"},{"ns":0,"exists":"","*":"Growth hormone"},{"ns":0,"exists":"","*":"Haemoglobin-based oxygen carriers"},{"ns":0,"exists":"","*":"Harvard University"},{"ns":0,"exists":"","*":"Helicobacter pylori"},{"ns":0,"exists":"","*":"Hemodialysis"},{"ns":0,"exists":"","*":"Hemoglobin"},{"ns":0,"exists":"","*":"Hemoperfusion"},{"ns":0,"exists":"","*":"Hepatocyte"},{"ns":0,"exists":"","*":"Hepatocytes"},{"ns":0,"exists":"","*":"Homogenizer"},{"ns":0,"exists":"","*":"Hormones"},{"ns":0,"exists":"","*":"Hypercholesterolemia"},{"ns":0,"exists":"","*":"Ifosfamide"},{"ns":0,"exists":"","*":"Immune modulation"},{"ns":0,"exists":"","*":"Immune response"},{"ns":0,"exists":"","*":"Immune system"},{"ns":0,"exists":"","*":"Immunoisolate"},{"ns":0,"exists":"","*":"Immunosuppression"},{"ns":0,"exists":"","*":"Inborn error of metabolism"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Ion channels"},{"ns":0,"exists":"","*":"Islets of Langerhans"},{"ns":0,"exists":"","*":"J. Craig Venter Institute"},{"ns":0,"exists":"","*":"Jeewanu"},{"ns":0,"exists":"","*":"Journal of the American Chemical Society"},{"ns":0,"exists":"","*":"Lactose intolerance"},{"ns":0,"exists":"","*":"Lesch-Nyhan syndrome"},{"ns":0,"exists":"","*":"Leukemia"},{"ns":0,"exists":"","*":"Leukocyte"},{"ns":0,"exists":"","*":"Lipid bilayer fusion"},{"ns":0,"exists":"","*":"Lipid membrane"},{"ns":0,"exists":"","*":"Lipid membranes"},{"ns":0,"exists":"","*":"Lipids"},{"ns":0,"exists":"","*":"Lipoproteins"},{"ns":0,"exists":"","*":"Liposome"},{"ns":0,"exists":"","*":"Liver failure"},{"ns":0,"exists":"","*":"Lymphosarcoma"},{"ns":0,"exists":"","*":"Macromolecule"},{"ns":0,"exists":"","*":"Macrophage"},{"ns":0,"exists":"","*":"McGill University"},{"ns":0,"exists":"","*":"Melanomas"},{"ns":0,"exists":"","*":"Metabolism"},{"ns":0,"exists":"","*":"Micelles"},{"ns":0,"exists":"","*":"Micro-encapsulation"},{"ns":0,"exists":"","*":"Molecular Weight Cut Off"},{"ns":0,"exists":"","*":"Monoclonal antibodies"},{"ns":0,"exists":"","*":"Monolayer"},{"ns":0,"exists":"","*":"Mutagenesis"},{"ns":0,"exists":"","*":"Mutate"},{"ns":0,"exists":"","*":"Mycobacterium tuberculosis"},{"ns":0,"exists":"","*":"Mycoplasma laboratorium"},{"ns":0,"exists":"","*":"Mycoplasma mycoides"},{"ns":0,"exists":"","*":"Na+/K+-ATPase"},{"ns":0,"exists":"","*":"Nanoparticle"},{"ns":0,"exists":"","*":"Necrosis"},{"ns":0,"exists":"","*":"Organ transplant"},{"ns":0,"exists":"","*":"Organelle"},{"ns":0,"exists":"","*":"PH"},{"ns":0,"exists":"","*":"Pancreatic cancer"},{"ns":0,"exists":"","*":"Parathyroid chief cell"},{"ns":0,"exists":"","*":"Peptides"},{"ns":0,"exists":"","*":"Perfusion"},{"ns":0,"exists":"","*":"Phospholipid bilayer"},{"ns":0,"exists":"","*":"Polylysine"},{"ns":0,"exists":"","*":"Polymers"},{"ns":0,"exists":"","*":"Polymersome"},{"ns":0,"exists":"","*":"Prodrugs"},{"ns":0,"exists":"","*":"Proteins"},{"ns":0,"exists":"","*":"Protocell"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"RNA"},{"ns":0,"exists":"","*":"RNA world hypothesis"},{"ns":0,"exists":"","*":"Ray Kurzweil"},{"ns":0,"exists":"","*":"Red blood cell"},{"ns":0,"exists":"","*":"Red blood cells"},{"ns":0,"exists":"","*":"Regenerative medicine"},{"ns":0,"exists":"","*":"Renal failure"},{"ns":0,"exists":"","*":"Respirocyte"},{"ns":0,"exists":"","*":"Rudolf Virchow"},{"ns":0,"exists":"","*":"ScienceDaily"},{"ns":0,"exists":"","*":"Self-replication"},{"ns":0,"exists":"","*":"Semipermeable"},{"ns":0,"exists":"","*":"Sol-gel"},{"ns":0,"exists":"","*":"Solubility"},{"ns":0,"exists":"","*":"Stem cells"},{"ns":0,"exists":"","*":"Surface area"},{"ns":0,"exists":"","*":"Suspension (chemistry)"},{"ns":0,"exists":"","*":"Synthetic Genomics"},{"ns":0,"exists":"","*":"Synthetic biology"},{"ns":0,"exists":"","*":"Targeted drug delivery"},{"ns":0,"exists":"","*":"Thermoplastic"},{"ns":0,"exists":"","*":"Thomas Chang"},{"ns":0,"exists":"","*":"Top-down and bottom-up design"},{"ns":0,"exists":"","*":"Toxicity"},{"ns":0,"exists":"","*":"Toxins"},{"ns":0,"exists":"","*":"Transcription (genetics)"},{"ns":0,"exists":"","*":"Transduction (genetics)"},{"ns":0,"exists":"","*":"Translation (biology)"},{"ns":0,"exists":"","*":"Tumor"},{"ns":0,"exists":"","*":"Type 1 diabetes"},{"ns":0,"exists":"","*":"Tyrosinase"},{"ns":0,"exists":"","*":"Tyrosine"},{"ns":0,"exists":"","*":"University of California"},{"ns":0,"exists":"","*":"Vaccines"},{"ns":0,"exists":"","*":"Vector (molecular biology)"},{"ns":0,"exists":"","*":"Volume"},{"ns":0,"*":"Microfluidizer"},{"ns":14,"exists":"","*":"Category:CS1 maint: Extra text: authors list"}],"templates":[{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg","Standard_and_drug_delivery_artificial_cells_.png","Artificial_cell_membranes.png","Cell_capsule_schematic.png"],"externallinks":["//doi.org/10.1016/j.tibtech.2005.05.008","//www.ncbi.nlm.nih.gov/pubmed/15935500","//doi.org/10.1126/science.1190719","//www.ncbi.nlm.nih.gov/pubmed/20488990","//doi.org/10.1126/science.146.3643.524","//www.ncbi.nlm.nih.gov/pubmed/14190240","//doi.org/10.1016/s0140-6736(89)90939-2","//www.ncbi.nlm.nih.gov/pubmed/2570944","//doi.org/10.1016/S0140-6736(94)90067-1","//www.ncbi.nlm.nih.gov/pubmed/12894754","//doi.org/10.1038/nm0696-696","//www.ncbi.nlm.nih.gov/pubmed/8640564","http://pubs.acs.org/doi/abs/10.1021/ja2076873","//doi.org/10.1021/ja2076873","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3262119","https://www.sciencedaily.com/releases/2012/01/120125132822.htm","http://www.kurzweilai.net/chemists-create-artificial-cell-membrane","http://www.gizmag.com/first-plastic-artificial-cell-working-organelles/30460/","//doi.org/10.1038/nchem.1840","https://healthunlocked.com/blf/posts/138847986/artificial-cells-are-tiny-bacteria-fighters.","https://www.firstpost.com/tech/science/researchers-create-artificial-lego-cells-that-can-detect-and-fight-bacteria-5108011.html","https://www.sciencedaily.com/releases/2018/09/180904093733.htm","//doi.org/10.3109/10731199209119658","//www.ncbi.nlm.nih.gov/pubmed/1391454","//doi.org/10.1038/229117a0","//www.ncbi.nlm.nih.gov/pubmed/4923094","//doi.org/10.1002/jps.10593","//www.ncbi.nlm.nih.gov/pubmed/14999721","//www.ncbi.nlm.nih.gov/pubmed/7093952","//doi.org/10.1081/bio-120028665","//www.ncbi.nlm.nih.gov/pubmed/15027798","//doi.org/10.1007/s00280-002-0448-0","//www.ncbi.nlm.nih.gov/pubmed/12042985","//doi.org/10.1159/000069147","//www.ncbi.nlm.nih.gov/pubmed/12649565","//doi.org/10.1006/mthe.2001.0305","//www.ncbi.nlm.nih.gov/pubmed/11319902","//doi.org/10.1016/j.ymgme.2003.08.016","//www.ncbi.nlm.nih.gov/pubmed/14567964","//doi.org/10.1126/science.288.5466.669","//www.ncbi.nlm.nih.gov/pubmed/10784449","//doi.org/10.1126/science.1088547","//www.ncbi.nlm.nih.gov/pubmed/14564000","//doi.org/10.1016/S0167-7799(98)01250-5","//www.ncbi.nlm.nih.gov/pubmed/10087608","//doi.org/10.1089/hum.1995.6.2-165","//www.ncbi.nlm.nih.gov/pubmed/7734517","//doi.org/10.1097/00002480-196504000-00035","//www.ncbi.nlm.nih.gov/pubmed/14329080","//doi.org/10.1111/j.1423-0410.1985.tb00196.x","//www.ncbi.nlm.nih.gov/pubmed/3892895","//doi.org/10.1081/bio-200039610","//www.ncbi.nlm.nih.gov/pubmed/15974179","//doi.org/10.1016/j.ijpharm.2004.10.028","//www.ncbi.nlm.nih.gov/pubmed/15778039","//doi.org/10.1089/dia.2005.7.968","//www.ncbi.nlm.nih.gov/pubmed/16386103","//doi.org/10.1080/11024159850191481","//doi.org/10.1097/TP.0b013e3181963ad3","//www.ncbi.nlm.nih.gov/pubmed/19307780","//doi.org/10.1081/bio-120003191","//www.ncbi.nlm.nih.gov/pubmed/12027231","//doi.org/10.1016/S0924-2244(00)00029-7","//www.ncbi.nlm.nih.gov/pubmed/12452406","//doi.org/10.1046/j.1365-2222.2000.00943.x","//www.ncbi.nlm.nih.gov/pubmed/11069570","//www.ncbi.nlm.nih.gov/pubmed/9508514","//doi.org/10.1016/S0958-6946(98)00074-0","//www.ncbi.nlm.nih.gov/pmc/articles/PMC143408","//doi.org/10.1128/IAI.71.1.101-108.2003","//www.ncbi.nlm.nih.gov/pubmed/12496154","//doi.org/10.1016/S0008-8749(02)00579-8","//www.ncbi.nlm.nih.gov/pubmed/12473264","//doi.org/10.1111/j.1525-1594.2004.07345.x","//www.ncbi.nlm.nih.gov/pubmed/15320945","//doi.org/10.3109/10731198809132551","//www.ncbi.nlm.nih.gov/pubmed/7461058","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131364","//doi.org/10.1073/pnas.1106634108","//www.ncbi.nlm.nih.gov/pubmed/21690347","//doi.org/10.1039/B717821B","http://www.mdpi.com/2075-1729/4/3/457/htm","//doi.org/10.3390/life4030457","//doi.org/10.1038/35053176","//www.ncbi.nlm.nih.gov/pubmed/11201752","//doi.org/10.1016/S0167-7799(02)01909-1","//www.ncbi.nlm.nih.gov/pubmed/11841864","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3048108","//doi.org/10.1073/pnas.1017075108","//www.ncbi.nlm.nih.gov/pubmed/21317359","//doi.org/10.1162/106454603322392479","//www.ncbi.nlm.nih.gov/pubmed/14556688","//doi.org/10.1038/319618a0","//doi.org/10.1038/nbt0909-783","//www.ncbi.nlm.nih.gov/pubmed/19741613","//doi.org/10.1038/465422a","//www.ncbi.nlm.nih.gov/pubmed/20495545","http://www.istpace.org//index.html","https://web.archive.org/web/20111214010917/http://www.ecltech.org/ecltech_j/","http://www.MICREAgents.eu/","http://www.informahealthcare.com/abb"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Artificial_cell","byteoffset":3947,"anchor":"History"},{"toclevel":1,"level":"2","line":"Materials","number":"2","index":"2","fromtitle":"Artificial_cell","byteoffset":10721,"anchor":"Materials"},{"toclevel":1,"level":"2","line":"Preparation","number":"3","index":"3","fromtitle":"Artificial_cell","byteoffset":12720,"anchor":"Preparation"},{"toclevel":2,"level":"3","line":"High-pressure homogenization","number":"3.1","index":"4","fromtitle":"Artificial_cell","byteoffset":13210,"anchor":"High-pressure_homogenization"},{"toclevel":2,"level":"3","line":"Microfluidization","number":"3.2","index":"5","fromtitle":"Artificial_cell","byteoffset":13485,"anchor":"Microfluidization"},{"toclevel":2,"level":"3","line":"Drop method","number":"3.3","index":"6","fromtitle":"Artificial_cell","byteoffset":14436,"anchor":"Drop_method"},{"toclevel":2,"level":"3","line":"Emulsion method","number":"3.4","index":"7","fromtitle":"Artificial_cell","byteoffset":14964,"anchor":"Emulsion_method"},{"toclevel":1,"level":"2","line":"Clinical relevance","number":"4","index":"8","fromtitle":"Artificial_cell","byteoffset":15314,"anchor":"Clinical_relevance"},{"toclevel":2,"level":"3","line":"Drug release and delivery","number":"4.1","index":"9","fromtitle":"Artificial_cell","byteoffset":15338,"anchor":"Drug_release_and_delivery"},{"toclevel":2,"level":"3","line":"Enzyme therapy","number":"4.2","index":"10","fromtitle":"Artificial_cell","byteoffset":15728,"anchor":"Enzyme_therapy"},{"toclevel":2,"level":"3","line":"Gene therapy","number":"4.3","index":"11","fromtitle":"Artificial_cell","byteoffset":20195,"anchor":"Gene_therapy"},{"toclevel":2,"level":"3","line":"Hemoperfusion","number":"4.4","index":"12","fromtitle":"Artificial_cell","byteoffset":24425,"anchor":"Hemoperfusion"},{"toclevel":2,"level":"3","line":"Encapsulated cells","number":"4.5","index":"13","fromtitle":"Artificial_cell","byteoffset":27871,"anchor":"Encapsulated_cells"},{"toclevel":3,"level":"4","line":"Encapsulated hepatocytes","number":"4.5.1","index":"14","fromtitle":"Artificial_cell","byteoffset":30135,"anchor":"Encapsulated_hepatocytes"},{"toclevel":3,"level":"4","line":"Encapsulated bacterial cells","number":"4.5.2","index":"15","fromtitle":"Artificial_cell","byteoffset":33513,"anchor":"Encapsulated_bacterial_cells"},{"toclevel":2,"level":"3","line":"Artificial blood cell","number":"4.6","index":"16","fromtitle":"Artificial_cell","byteoffset":38187,"anchor":"Artificial_blood_cell"},{"toclevel":3,"level":"4","line":"Oxygen carriers","number":"4.6.1","index":"17","fromtitle":"Artificial_cell","byteoffset":38216,"anchor":"Oxygen_carriers"},{"toclevel":3,"level":"4","line":"Red blood cells","number":"4.6.2","index":"18","fromtitle":"Artificial_cell","byteoffset":39146,"anchor":"Red_blood_cells"},{"toclevel":3,"level":"4","line":"Leuko-polymersome","number":"4.6.3","index":"19","fromtitle":"Artificial_cell","byteoffset":41193,"anchor":"Leuko-polymersome"},{"toclevel":1,"level":"2","line":"Synthetic cells","number":"5","index":"20","fromtitle":"Artificial_cell","byteoffset":42025,"anchor":"Synthetic_cells"},{"toclevel":2,"level":"3","line":"The minimal cell","number":"5.1","index":"21","fromtitle":"Artificial_cell","byteoffset":42046,"anchor":"The_minimal_cell"},{"toclevel":2,"level":"3","line":"Electronic artificial cell","number":"5.2","index":"22","fromtitle":"Artificial_cell","byteoffset":47828,"anchor":"Electronic_artificial_cell"},{"toclevel":2,"level":"3","line":"Ethics and controversy","number":"5.3","index":"23","fromtitle":"Artificial_cell","byteoffset":51794,"anchor":"Ethics_and_controversy"},{"toclevel":1,"level":"2","line":"See also","number":"6","index":"24","fromtitle":"Artificial_cell","byteoffset":52550,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"7","index":"25","fromtitle":"Artificial_cell","byteoffset":52680,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"8","index":"26","fromtitle":"Artificial_cell","byteoffset":52712,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Artificial cell","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q1176234"}]}}